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The chemical composition, in vitro genotoxicity, and cytotoxicity of the mainstream aerosol from the
Tobacco Heating System 2.2 (THS2.2) were compared with those of the mainstream smoke from the 3R4F
reference cigarette. In contrast to the 3R4F, the tobacco plug in the THS2.2 is not burnt. The low operating
temperature of THS2.2 caused distinct shifts in the aerosol composition compared with 3R4F. This
resulted in a reduction of more than 90% for the majority of the analyzed harmful and potentially
harmful constituents (HPHCs), while the mass median aerodynamic diameter of the aerosol remained
similar. A reduction of about 90% was also observed when comparing the cytotoxicity determined by the
neutral red uptake assay and the mutagenic potency in the mouse lymphoma assay. The THS2.2 aerosol
was not mutagenic in the Ames assay. The chemical composition of the THS2.2 aerosol was also eval-
uated under extreme climatic and pufﬁng conditions. When generating the THS2.2 aerosol under
“desert” or “tropical” conditions, the generation of HPHCs was not signiﬁcantly modiﬁed. When using
pufﬁng regimens that were more intense than the standard Health Canada Intense (HCI) machine-
smoking conditions, the HPHC yields remained lower than when smoking the 3R4F reference cigarette
with the HCI regimen.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The U.S. Family Smoking Prevention and Tobacco Control Act
(FSPTCA) deﬁnes a Modiﬁed Risk Tobacco Product (MRTP) as “any
tobacco product that is sold or distributed for use to reduce harm
or the risk of tobacco related disease associated with commercially
marketed tobacco products” (Family Smoking Prevention and
Tobacco Control Act, 2009). This publication is part of a series of
nine publications describing the nonclinical and part of the clinical
assessment of a candidate MRTP, THS2.2 regular and a mentho-
lated version (THS2.2M). The series of publications provides part. Schaller).
Inc. This is an open access article uof the overall scientiﬁc program to assess the potential for THS2.2
to be a reduced risk product. The ﬁrst publication in this series
describes THS2.2 and the assessment program for MRTPs (Smith
et al., 2016). This is followed by six publications, including this
one, that describe the nonclinical assessment of THS2.2 regular
and THS2.2M (Kogel et al., 2016; Oviedo et al., 2016; Schaller et al.,
2016a; Schaller et al., 2016b; Sewer et al., 2016; Wong et al., 2016).
The eighth publication in the series describes a clinical study to
assess whether the reduced formation of Harmful and Potentially
Harmful Constituents (HPHCs) for THS2.2 regular also leads to
reduced exposure to HPHCs when the product is used in a clinical
setting (Haziza et al., 2016). A ﬁnal publication utilizes data
gathered from the reduced exposure clinical study on THS2.2
regular to determine if a systems pharmacology approach can
identify exposure response markers in peripheral blood ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations
(NNK) 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone
(EHCSS) Electrically Heated Cigarette Smoking System
(FID) ﬂame ionization detection
(GC/MS) gas chromatograph-mass spectrometer
(GC) gas chromatography
(GVP) gas-vapor phase
(GEF) global evaluation factor
(HPHC) harmful and potentially harmful constituent
(HCI) Health Canada Intense
(ICP-MS) inductively coupled plasma mass spectrometry
(IARC) International Agency for Research on Cancer
(LOQ) limit of quantiﬁcation
(LC-MS/MS) liquid chromatograph tandem mass spectrometer
(LC) liquid chromatography
(LB) lower boundaries
(LOGEL) lowest observed genotoxic effect level
(MMAD) mass median aerodynamic diameter
(MRTP) Modiﬁed Risk Tobacco Product
(MLA) mouse lymphoma assay
(MF) mutation frequency
(NRU) neutral red uptake
(NFDPM) nicotine-free dry particulate matter
(NOx) nitrogen oxides
(NAB) N-nitrosoanabasine
(NAT) N-nitrosoanatabine
(NNN) N-nitrosonornicotine
(PBS) phosphate-buffered saline
(PDSP) programmable dual syringe pump
(RH) relative humidity
(RTG) relative total growth
(IP) Intermediate Precision
(THS2.2) Tobacco Heating System 2.2
(TPM) total particulate matter
(UB) upper boundaries
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is the second of the series and presents the chemical analyses, the
physical characterization, and the in vitro genotoxicity and cyto-
toxicity assessments of the mainstream aerosol of the THS2.2.
The smoke produced by the combustion of tobacco in a
combustible cigarette (CC) is a complex and dynamic chemical
mixture which contains more than 8000 identiﬁed chemical
compounds (Rodgman and Perfetti, 2013). Tobacco smoke from CC
consists of an aerosol containing liquid droplets (‘particulate
phase’) suspended in a carrier gas and surrounded by its own gas-
vapor phase. It is generated by complex and overlapping burning,
pyrolysis, pyrosynthesis, distillation, sublimation, and condensa-
tion processes (Borgerding and Klus, 2005). With minor excep-
tions, both pyrogenesis and pyrosynthesis of HPHCs result from
the thermal decomposition of organic compounds present in to-
bacco occurring at temperatures up to 900 C observed in ciga-
rettes (Torikaiu et al., 2005; Baker, 2006); thus, a reduction of
these toxicants may be achieved by heating rather than burning
tobacco to produce an aerosol. The development of heat-not-burn
tobacco products is not new and earlier efforts to develop such
products (notably Premier and Eclipse products from The R.J.
Reynolds Tobacco Company and Accord from Philip Morris) have
been reviewed by Baker (Baker, 2006). The Electrically Heated
Cigarette Smoking System (EHCSS) was the ﬁrst generation of
tobacco heated products commercialized by Philip Morris. The
EHCSS series-E has been subject to extensive analytical and toxi-
cological evaluation, demonstrating simpliﬁed smoke chemistry
compared with the 1R4F reference cigarette of the University of
Kentucky (Patskan and Reininghaus, 2003). Notably there was a
signiﬁcant reduction in carbon monoxide (CO) and an increased
yield of formaldehyde in EHCSS-E mainstream smoke, compared
with the 1R4F cigarette. On a per-milligram total particulate
matter (TPM) basis, the concentration of formaldehyde was
increased approximately sevenfold (Stabbert et al., 2003). In later
developments of EHCSS (series-JLI and series-K), in order to
reduce these excessive levels of formaldehyde, ammonium mag-
nesium phosphate (AMP) was used in the cigarette paper to
replace calcium carbonate. It was anticipated that ammonia
released during the pyrolysis of AMP would condense with
formaldehyde to form hexamethylenetetramine (HMT) (Schorpet al., 2012). Chemical analysis of smoke from the EHCSS-JLI and
EHCSS-K cigarettes containing AMP showed lower yields of
formaldehyde and several HPHCs, a further decrease in CO yield,
and increased yields of ammonia and HMT (Roemer et al., 2008;
Werley et al., 2008; Zenzen et al., 2012). The THS2.2 is the latest
generation of heat-not-burn products from Philip Morris Interna-
tional. It produces an aerosol by carefully heating the tobacco with
a heater blade reaching a maximum temperature of 350 C. This
system enables a careful control of the energy applied to the to-
bacco plug (Smith et al., 2016) and limits the thermal physico-
chemical processes while producing an aerosol capable of
satisfying adult smokers enabling them to switch from cigarettes.
Although the causal relationship between smoking and several
diseases is well established (Doll et al., 2004), there is still very
little understanding of the underlying mechanisms by which
smoking causes disease. Among the more than 8000 chemical
compounds that have been identiﬁed in cigarette tobacco smoke
(Rodgman and Perfetti, 2013), public health authorities and others
have proposed some 100 HPHCs as possible causes of smoking-
related diseases such as lung cancer, heart disease, and emphy-
sema (Health Canada, 2000; World Health Organisation, 2008; U.S.
Food and Drug Administration, 2012). For the US Food and Drug
Administration, the notion of “harmful and potentially harmful
constituent” includes any chemical or chemical compound in a
tobacco product or in tobacco smoke that is, or potentially is,
inhaled, ingested, or absorbed into the body, including as an
aerosol (vapor) or any other emission; and causes or has the po-
tential to cause direct or indirect harm to users or non-users of
tobacco products (U.S. Food and Drug Administration, 2016).
However, there is no consensus, that lowering or eliminating any
single compound (or even a combination of compounds) in smoke
would have a signiﬁcant impact on risk. The current approach,
which eliminates direct tobacco combustion and limits tobacco
pyrolysis by heating at signiﬁcantly lower temperatures than
encountered in CC, has the potential to reduce a broad range of
HPHCs in the THS2.2 aerosol. Consequently, criteria were estab-
lished to develop a list of relevant analytes, including HPHCs to
assess their reductions in the THS2.2 aerosol, compared to the
mainstream smoke of the University of Kentucky reference ciga-
rette 3R4F, as follows:
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Organization for Standardization (ISO) methods. This list in-
cludes total particulate matter (TPM) (International
Organisation for Standardization, 2011), water in TPM
(International Organisation for Standardization, 2011), nicotine
(International Organisation for Standardization, 2013), nicotine-
free dry particulate matter (NFDPM) (International Organisation
for Standardization, 2011); carbonmonoxide (CO) (International
Organisation for Standardization, 2010b) and benzo[a]pyrene
(International Organisation for Standardization, 2012).
 Criterion 2: Priority toxicants in tobacco smoke selected from
the lists issued by regulatory bodies, or proposed by cognizant
authorities (Health Canada, 2000; World Health Organisation,
2008; U.S. Food and Drug Administration, 2012). This list in-
cludes the analytes recommended by ISO under Criterion 1. In
addition, the following HPHCs are also included: 1-
aminonaphthalene, 2-aminonaphthalene, 3-aminobiphenyl, 4-
aminobiphenyl, acetaldehyde, acetone, acrolein, butyralde-
hyde, crotonaldehyde, formaldehyde, methyl ethyl ketone,
propionaldehyde, acrylonitrile, 1,3-butadiene, benzene,
isoprene, pyridine, quinoline, styrene, toluene, catechol, m-
cresol, p-cresol, o-cresol, hydroquinone, phenol, resorcinol, N-
nitrosoanabasine (NAB), N-nitrosoanatabine (NAT), 4-(N-nitro-
somethylamino)-1-(3-pyridyl)-1-butanone (NNK), N-nitro-
sonornicotine (NNN), ammonia, hydrogen cyanide, nitric oxide
(NO), nitrogen oxides (NOx), arsenic, cadmium, chromium, lead,
mercury, nickel, and selenium.
 Criterion 3: Toxicants with an established biomarker of expo-
sure, i.e., for use in a clinical study to determine exposure to the
parent toxicant (Haziza et al., 2016). The toxicants include some
analytes already listed under “Criterion 1” and “Criterion 2”: CO
(biomarker: blood carboxyhemoglobin (COHb) (Pojer et al.,
1984), nicotine (biomarker: serum cotinine (Benowitz and Iii,
1984) or total nicotine equivalents in urine (Benowitz and
Jacob, 1994)), 2-aminonaphthalene, 4-aminobiphenyl and o-
toluidine (biomarker: parent amines in urine (Riedel et al.,
2006)), acrolein (biomarker: 3-hydroxypropylmercapturic acid
(3-HPMA) in urine (Mascher et al., 2001)), crotonaldehyde
(biomarker: 3-hydroxy-2-methylpropyl mercapturic acid
(HMPMA) in urine (Scherer et al., 2007)), acrylonitrile
(biomarker: 2-cyanoethylmercapturic acid (CEMA) in urine
(Minet et al., 2011)), acrylamide (biomarker: acrylamide mer-
capturic acid (AAMA) in urine (Urban et al., 2006)), 1,3-
butadiene (biomarker: 1-hydroxy-2-(N-acetyl-cysteineyl)-3-
butene (MHBMA) in urine (van Sittert et al., 2000)), benzene
(biomarker: S-phenylmercapturic acid (S-PMA) in urine
(Medeiros et al., 1997)), NNK (biomarker: total 4-(methylni-
trosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine (Carmella
et al., 2003)), NNN (total NNN in urine (Kavvadias et al.,
2009)), benzo[a]pyrene and pyrene (biomarker: total 1-
hydroxypyrene (1-OHP) in urine (Strickland et al., 1996)).
 Criterion 4: Toxicants which are predominantly formed below
400 C, and which are not included under “Criterion 2”: acryl-
amide (possibly formed from asparagine and reducing sugars
through a Maillard type of reaction occurring between 120 and
200 C (Stadler et al., 2002; Blank et al., 2005; Becalski et al.,
2011)), acetamide (possibly formed from the pyrolysis of Ama-
dori compounds (formed by the reaction of amino acids and
sugars) and from the decomposition of ammonium acetate at
around 250 C (Moldoveanu, 2010)), propylene oxide (possibly
formed by dehydration of propylene glycol which is used as a
humectant in CC and for application of ﬂavors to tobacco
(Diekmann et al., 2006; Laino et al., 2012)), nitrobenzene,
ethylene oxide and vinyl chloride (the source of the 3 last
compounds is less clear but ethylene oxide and vinyl chlorideare both classiﬁed by the International Agency for Research on
Cancer (IARC) as Group 1 (carcinogenic to humans), and nitro-
benzene as Group 2B (possibly carcinogenic to humans)).
 Criterion 5: Toxicants which are predominantly formed above
400 C, and which are not included under “Criterion 1” and
“Criterion 2”: dibenz[a,h]anthracene and benz[a]anthracene
(McGrath et al., 2007).
In addition, glycerin (a humectant used during CC and Tobacco
stickmanufacturing) and menthol (for mentholated products only)
were also quantiﬁed. This results in a total of 59 analytes for THS2.2
regular products (60 for mentholated products) that were quanti-
ﬁed to perform the chemical assessment of the THS2.2 aerosol.
Among them, 54 are HPHCs targets for reduction compared to 3R4F
when developing heat-not-burn products: carbon monoxide, benzo
[a]pyrene, 1-aminonaphthalene, 2-aminonaphthalene, 3-
aminobiphenyl, 4-aminobiphenyl, acetaldehyde, acetone, acrolein,
butyraldehyde, crotonaldehyde, formaldehyde, methyl ethyl ke-
tone, propionaldehyde, acrylonitrile, 1,3-butadiene, benzene,
isoprene, pyridine, quinoline, styrene, toluene, catechol, o-cresol,
m-cresol, p-cresol, hydroquinone, phenol, resorcinol, NAB, NAT,
NNK, NNN, ammonia, hydrogen cyanide, nitric oxide, nitrogen ox-
ides, arsenic, cadmium, chromium, lead, mercury, nickel, selenium,
pyrene, o-toluidine, acetamide, acrylamide, ethylene oxide, nitro-
benzene, propylene oxide, vinyl chloride, benz[a]anthracene and
dibenz[a,h]anthracene. As previously mentioned, this list was
mainly based on analytes proposed by public health authorities and
it covers a large range of potential toxicants identiﬁed in cigarette
smoke. However, the scientiﬁc literature continues to describe new
compounds with a potential toxicity mainly in aerosols from new
products. For instance, only recently has glycidol been identiﬁed as
a potential toxic compound in aerosols from electronic cigarettes
(Sleiman et al., 2016). The present list of HPHCs was based on
knowledge available at the time of designing the studies and gly-
cidol, which was not included in the FDA list (U.S. Food and Drug
Administration, 2012), was not identiﬁed at the time as a poten-
tial target to be included.
In addition to the 54 HPHCs listed above, TPM, water, nicotine,
NFDPM, glycerin and menthol (for mentholated products only) are
used to assess product performance but are not targets for reduc-
tion compared to the 3R4F. These analytes are major aerosol con-
stituents for which the level has to be maintained in order to
provide satisfactory sensory properties. For instance, nicotine is
addictive and has toxic properties. However, at the levels nicotine is
consumed from tobacco products, it is not considered to be a pri-
mary cause of smoking related disease (The Royal College of
Physicians, 2016). As noted by the Royal College of Physicians
(The Royal College of Physicians, 2016) “The ideal harm-reduction
device should therefore deliver nicotine in a manner as similar as
possible to cigarettes, while at the same time maximizing palat-
ability and nicotine delivery to approximate the experience of
cigarette smoking more closely.” Following this logic, the nicotine
content in the delivered aerosol was carefully monitored and the
nicotine level was by designmaintained at an appropriate level. It is
important to note that, although TPM and NFDPM are analytes that
were originally deﬁned in the context of CC smoke, they can also be
used in the context of aerosol produced by heating tobacco, as they
characterize the mass of aerosol delivered. However, TPM and
NFDPM yields obtained from heated products should not be
directly compared to the values obtained for cigarettes, as the
smoke produced by combustion and the aerosol produced by
heating tobacco have substantially different chemical
compositions.
The exposure to HPHCs may also be affected by the physical
properties of the inhaled aerosol. The particle/droplet size
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to pass through the upper respiratory tract to reach the lungs and
the fraction that is retained in the respiratory system (Robinson and
Yu, 2001; Bernstein, 2004; Kane et al., 2010). An aerosol is
considered respirable when the mass median aerodynamic diam-
eter (MMAD) calculated from the measured size distribution is
below 2.5 mm (Hinds, 1999). In the past decades, several in-
struments have been used to determine the size distributions of CC
mainstream smoke, and more recently, of e-cigarette aerosols as
well (Singh et al., 2006; Ingebrethsen et al., 2012; Fuoco et al., 2014;
Geiss et al., 2015). These analytical techniques have been shown to
have both advantages and drawbacks in measuring the aerosol
physical parameters. Past studies revealed that different method-
ologies led to size distributions ranging from 0.2 to 0.9 mm for CC
smoke (Ishizu et al., 1978; Davies, 1988). This wide range of droplet
sizes obtained for CC was presumably due to particular aerosol
sampling and dilution methodologies. The methodologies enabling
a real-time aerosol physical characterization used the measured
aerosol number size distribution to calculate the related mass
concentration distribution and the MMAD, assuming spherical
particles or droplets with a chosen arbitrary density. Consequently,
the conversion from number to mass distribution could lead to the
overestimation or underestimation of the MMAD. To minimize
these problems, the selected physical characterization of the
aerosol was based on multistage cascade impactor technology,
allowing a determination of the MMAD. The impactor technique
enabled the gravimetrical classiﬁcation of aerosol droplets in
distinct size classes, and was often associated with the related
aerosol deposition behavior in lungs (Hinds,1999). Additionally, the
technique allowed the determination of the MMAD assuming
equivalent unit density and spherical droplet shapes.
The development of a new product such as the THS2.2 should be
accompanied not only by the analysis of its chemical composition
but also by in vitro and in vivo toxicological assays, because current
knowledge is insufﬁcient for predicting the effect of complex
mixtures based solely on the chemical composition (Carchman,
1988; Institute of Medicine, 2001; Tewes et al., 2003). To further
extend the characterization of the THS2.2 aerosol, both the cyto-
toxic and mutagenic activity of the aerosol were compared to the
activities of mainstream smoke of the reference cigarette 3R4F.
Furthermore, two 90-day rodent inhalation studies are also re-
ported in this issue (Sewer et al., 2016; Wong et al., 2016).
The current studies report the aerosol characterization from 4
different versions of the THS2.2 Tobacco Sticks: two THS2.2 Reg-
ular (THS2.2 FR1 and THS2.2 D2) and two THS2.2 Menthol (THS2.2
FR1 M and THS2.2 D1 M). These studies include the cytotoxic and
genotoxic activities of the mainstream THS2.2 aerosol compared
to mainstream smoke of the reference cigarette 3R4F and a
comprehensive physical and chemical characterization of the
produced aerosols. For both types of aerosols, the cytotoxicity of
the gas-vapor phase (GVP) and the particulate phase (TPM) was
assessed using the neutral red uptake (NRU) assay (Borenfreund
and Puerner, 1985) and the genotoxicity was assessed using both
the Salmonella typhimurium reverse mutation assay (TPM only)
(Ames (Ames et al., 1973)) and the mouse lymphoma assay (MLA)
(Clive et al., 1972). The physicochemical characterization was
based on the comparison of the droplet diameter of both aerosols
and the presence of 54 HPHCs in each aerosol using the Health
Canada Intense (HCI) machine-smoking protocol (Health Canada,
2000). In addition, the THS2.2 aerosol chemical composition was
assessed under different climatic conditions (temperature and
relative humidity) and with different machine-smoking regimens
to simulate different use than described in the HCI machine-
smoking protocol.2. Materials and methods
2.1. Reference cigarette
The 3R4F reference cigarette was obtained from the University
of Kentucky (Lexington, KY, USA; http://www.ca.uky.edu/refcig/).
2.2. THS2.2 tobacco stick
The tobacco stick was designed to be used with the THS2.2
holder (Smith et al., 2016). Its construction is shown in Fig. 1.
A tobacco stick is constructed by the sequential assembly of the
following components:
1. Tobacco plug wrapped in a paper over-wrap.
2. Hollow acetate tube wrapped in a paper over-wrap.
3. Polymer-ﬁlm ﬁlter, wrapped in a paper over-wrap.
4. Mouthpiece ﬁlter wrapped in a paper over-wrap.
All these elements are wrapped in an outer paper, and a tipping
paper is added on the mouth end (Fig. 1).
Unlike CC, the THS tobacco stick does not burn when used, and
thus its length remains unchanged. The tobacco plug is made of
reconstituted cast leaf tobacco containing various tobacco types
from different origins, as well as binders and humectants. The
humectants were added to prevent the cast leaves becoming too
brittle. Heating the humectants caused them to evaporate and re-
condense to form small droplets, generating a visible aerosol.
Four different tobacco stick variants were used for aerosol charac-
terization: two versions of the THS2.2 Regular (THS2.2 FR1 and
THS2.2 D2) and two versions of the THS2.2 Menthol (THS2.2 FR1 M
and THS2.2 D1 M). These four THS2.2 tobacco sticks contain ﬂavor
ingredients. THS2.2 FR1 M and THS2.2 D1 M contain natural l-
menthol applied to a cellulose acetate yarn included in the
polymer-ﬁlm ﬁlter and to the inner liner paper included in the
tobacco stick pack. FR1, D2 and D1 are different tobacco blends but
the tobacco sticks were of the same design.
2.3. Cambridge glass-ﬁber ﬁlter pad, cigarette, and tobacco stick
conditioning
The reference cigarette 3R4F and THS2.2 tobacco sticks were
stored at 5 ± 3 C with uncontrolled humidity conditions in the
original packaging, before conditioning. For the ISO/Health Canada
conditioning, test articles were conditioned for at least 48 h at
22 ± 1 C and 60± 2% relative humidity (RH), according to the In-
ternational Organization for Standardization (ISO) method 3402
(International Organisation for Standardization, 2010a). Cambridge
glass-ﬁber ﬁlter pads were conditioned under the same conditions.
Prior to the analyses performed in “tropical“ and “desert“ con-
ditions, test articles were either conditioned for at least 48 h at
30 ± 1 C and 75± 2% RH (“tropical“ conditions), or at 30 ± 1 C and
35± 2% RH (“desert“ conditions). The corresponding Cambridge
glass-ﬁber ﬁlter pads were conditioned under the same climatic
conditions.Fig. 1. THS2.2 tobacco stick.
J.-P. Schaller et al. / Regulatory Toxicology and Pharmacology 81 (2016) S27eS47 S312.4. Generation of THS2.2 aerosol and mainstream smoke of 3R4F
according to the HCI machine-smoking regimen
The mainstream aerosol of THS2.2 and the smoke of the refer-
ence cigarette 3R4F were generated on a Borgwaldt linear smoking
machine type LM20X (Borgwaldt KC GmbH, Hamburg, Germany)
for the determination of all analytes (except elements) according to
the HCI machine-smoking regimen (Health Canada, 2000). For the
elements, the mainstream aerosol of THS2.2 and the smoke of the
reference cigarette 3R4F were generated from a Burghart rotary
smoking machine type RMB 20 (Burghart Tabaktechnik GmbH,
Wedel, Germany) with the same smoking regimen.
For the in vitro biological assays test battery (Ames, MLA, and
NRU), the 3R4F mainstream smoke and THS2.2 aerosols were
generated using a Burghart rotary smoking machine type RMB 20
(Burghart Tabaktechnik GmbH, Wedel, Germany) according to the
Health Canada Intense (HCI) smoking regimen (Health Canada,
2000). The generated aerosol and smoke were trapped to
analyze the aerosols. After trapping, the samples were analyzed
and processed (section 2.7). Processing describes the conversion
from a primary result, e.g., a peak area or counts to a value per
cigarette or per stick, taking the number of accumulations, the
trapping or extraction volume or dilution into account. For in vitro
assessments, the aerosol was fractionated into two parts, TPM and
GVP, during the same aerosol collection (except for the Ames
assay, where only TPM was tested). At the end of the aerosol
generation, the collected TPM aerosol fraction on the Cambridge
glass-ﬁber ﬁlter pad was solubilized in dimethyl sulfoxide
(DMSO), and the water-soluble GVP fractionwas immobilized into
an impinger of ice-cold Ca2þ and Mg2þ-free phosphate-buffered
saline (PBS) solution.
The reference cigarette 3R4F was smoked to a butt length of
35 mm using a bell-shaped puff proﬁle and 100% blocking of
ventilation holes. THS2.2 Regular and Menthol tobacco sticks were
‘smoked’ using a bell-shaped puff proﬁle to a deﬁned puff count of
12 puffs. The limitation to 12 puffs is based on the ﬁxed settings of
the THS2.2 system, which is programmed to ﬁnish heating after a
maximum period of 6 min, and the puff interval of the HCI regimen
(30 s).Table 2
Smoking machine settings for the generation of THS2.2 aerosol generation under
alternative pufﬁng regimens.
Regimen Puff volume Puff duration Puff interval Number of puffsa
[ml] [s] [s] [n]2.5. Generation of THS 2.2 aerosol under different climatic
conditions
THS2.2 aerosol was generated under different ambient tem-
perature and RH conditions of 22 ± 2 C and 60± 5% RH, 30 ± 2 C
and 75± 5% RH, and 30 ± 2 C and 35± 5% RH to simulate “Medi-
terranean”, “Tropical“ and “Desert“ climates, respectively (Table 1),
using a linear smoking machine prototype SM405XR (Cerulean
Molins PLC, Milton Keynes, UK) and the HCI machine-smoking
regimen (Health Canada, 2000). The smoking machine was
housed in a conditioned air cabinet (temperature range:
10 Ce35 C; humidity range: 10%e80% RH) ﬁtted with a Delta 335
air conditioning unit (Design Environmental Ltd, Ebbw Vale, UK).
The atmosphere of the cabinet was constantly refreshed with
conditioned air. The temperature and RH in the cabinet wasTable 1
Climatic conditions.
Conditions Temperature Relative Humidity
[C] [% RH]
Mediterranean 22 ± 2 60± 5%
Tropical 30 ± 2 75± 5%
Desert 30 ± 2 35± 5%monitored using a TH1 dataloger (ELPRO-Buchs AG, Buchs,
Switzerland).
2.6. Generation of THS2.2 aerosol under alternative pufﬁng
regimens
THS2.2 aerosol was generated according to the alternative
pufﬁng regimen presented in Table 2. A Cerulean SM450RH
smoking machine (Cerulean Molins PLC, Milton Keynes, UK) was
used to generate aerosols for the analysis of all analytes except
nitric oxide (NO) and nitrogen oxides (NOx). The NO and NOx
measurements were performed on a Borgwaldt linear smoking
machine type LM20X (Borgwaldt KC GmbH, Hamburg, Germany).
Since this smoking machine is limited to puffs of 100 ml, NO and
NOx measurement were not performed for the LR-3 regimen
(Table 2).
The alternative pufﬁng regimens (SR-1, SR-4, SR-5, SR-6 and LR-
3) were selected according to human pufﬁng behavior observed
with THS2.2 users (Campelos et al., 2016).
2.7. Chemical analyses
All analytes were determined using 15 separate aerosol and
smoke generations. The 15 separate analyte groups and corre-
sponding individual analytes are shown in Table 3.
The description of the analytical methods used to quantify the
analytes in the THS2.2 aerosol and in the smoke of the 3R4F
reference cigarette are presented in the supplementary material
section.
2.8. Physical measurements
The droplet size distribution measurements were conducted
using a PIXE multistage cascade impactor (PIXE International Corp.,
Tallahassee, FL USA) using a sampling ﬂow rate of 1 l/min. During
this study, the PIXE cascade impactor was composed of nine
impactor stages. For both 3R4F and THS2.2 Tobacco Sticks, the
average mass median aerodynamic diameter (MMAD) and geo-
metric standard deviation (GSD) were estimated from 10 replicate
aerosol samples. The average GSD was determined as the square
root of the average GSD2. The test items were connected to the inlet
of a programmable dual syringe pump (PDSP) (Burghart Mes-
stechnik GmbH, Wedel, Germany). The outlet of the PDSP was
connected to a glass T-junction that allowed aerosol transfer before
it entered the PIXE cascade impactor. The outlet of the PIXE cascade
impactor was connected to a pump (Vacuubrand GmbH þ CO KG,
Wertheim, Germany) (Fig. 2).ISO 35 2.0 60 6
SR-1 40 2.4 30 8
SR-5 80 2.4 30 8
HCI 55 2.0 30 12
SR-4 60 2.4 25 14
SR-6 80 2.4 25 14
LR-3 110 4.5 22 14
a The number of puffs results from puff intervals of the different smoking regi-
mens and the ﬁxed settings of the THS2.2 system, which is programmed to ﬁnish
heating after a maximum period of 6 min and allows up to 14 puffs to be taken
during that time.
Table 3
Analyte groups and corresponding individual analytes.
Analyte Group Individual Analytes
ISO parameters and product-
speciﬁc constituents
Total particulate matter (TPM), water, nicotine, nicotine-free dry particulate matter (NFDPM),
carbon monoxide (CO), glycerol
Volatiles- and semi-volatiles 1,3-butadiene, isoprene, benzene, toluene, styrene, pyridine, quinoline, acrylonitrile
Carbonyls acetaldehyde, acetone, acrolein, butyraldehyde, crotonaldehyde, formaldehyde, methyl
ethyl ketone, propionaldehyde
Aromatic amines 1-aminonaphthalene, 2-aminonaphthalene, 3-aminobiphenyl, 4-aminobiphenyl, o-toluidine
Nitrogen oxides nitric oxide (NO), oxides of nitrogen (NOx)
Hydrogen cyanide hydrogen cyanide
Ammonia Ammonia
Epoxides and vinyl chloride ethylene oxide, propylene oxide, vinyl chloride
Tobacco-speciﬁc nitrosamines N-nitrosoanabasine (NAB), N-nitrosoanatabine (NAT), N-nitrosonornicotine (NNN), 4-(N-nitrosomethylamino)-1-
(3-pyridyl)-1-butanone (NNK)
Phenols and acid derivatives catechol, o-cresol, m-cresol, p-cresol, hydroquinone, phenol, resorcinol, acetamide, acrylamide
Polycyclic aromatic hydrocarbons benzo[a]pyrene, benz[a]anthracene, dibenz[a,h]anthracene, pyrene
Nitrobenzene Nitrobenzene
Elements (except mercury) arsenic, cadmium, chromium, lead, nickel, selenium
Mercury Mercury
Menthol Menthol
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measurement. The following steps were performed:
1. Calculation of the net weight for each impactor stage of the
cascade impactor: DMi ¼ [Weight loaded (g)]i  [Weight empty
(g)]i (i ¼ 1,…, i).
2. Calculation of the total mass by summing up all of the i net
weights: TM ¼P DMi.
3. Calculation of the mass fraction for each stage: Mfi ¼ DMi/TM
(i ¼ 1, …, i).
4. Normalization of themass fraction for each stage by thewidth of
successive cutoff diameter [DD50%]: The cutoff diameter rep-
resents the smaller size that can be captured on the related
stage, whereas the maximum size collected on that stage is
related to the next larger cutoff diameter.
nMfi ¼ Mfi/[DD50%]i (i ¼ 1,…, i)
The values for the cutoff diameters [DD50%]i (i ¼ 1, …, i) are
given in Table 4.
5. The calculation of theMMAD and GSDwas performed using Igor
Pro version 6.3.2.3 (WaveMetrics, Inc., Lake Oswego, OR, USA)
using a lognormal mono-modal ﬁtting distribution (Equation
(1)) of the normalized mass fraction nMfi vs. the respective mid-
point diameter Di
f ðddÞ ¼
1
dd lnðGSDÞ
ﬃﬃﬃﬃﬃﬃ
2p
p e
ðlnðddÞlnðMMADÞÞ2
2ðlnðGSDÞÞ2 (1)Fig. 2. Experimental setup for aerosol physical measurement.where dd is the size diameter in micrometers, GSD is the geometric
standard deviation, MMAD is the mass median aerodynamic
diameter, and f(dd) represents the normalized mass fraction data.
The mass of each impactor stage was recorded prior to and after
each aerosol collection. Subsequently, the mass fraction deposited
on the different impactor stages was calculated, whereas the size
bins were normalized by dividing the mass fractions with their
respective widths. This process permitted the transformation of
discrete data points into density functions that could be ﬁtted with
a continuous lognormal distribution function, fromwhich both the
MMAD and the GSD were calculated. The negative values were not
replaced by zero. The lower boundaries (LB) and upper boundaries
(UB) were calculated at the 95% conﬁdence interval using the
following equation:
LB ¼ MMAD=GSD2; UB ¼MMAD GSD22.9. In vitro toxicology
All in vitro studies were performed in full accordance with the
principles of Good Laboratory Practice.2.9.1. Neutral RED uptake (NRU) assay
The mouse embryonic ﬁbroblast cell line Balb/c 3T3 (clone A31)
was obtained from the European Collection of Authenticated Cell
Cultures (Salisbury, UK), and was used to perform the NRU assay
according to INVITTOX protocol 3a (INVITTOX, 1990), with some
modiﬁcations (Borenfreund and Puerner, 1985). Sodium dodecylTable 4
Cutoff diameters and mid-point diameters for each stage of the PIXE cascade
impactor.
Stage Cutoff diameter (mm) Mid-point (mm)
DD50% Di
7 16 16
6 8 12
5 4 6
4 2 3
3 1 1.5
2 0.5 0.75
1 0.25 0.375
L2 0.12 0.185
L1 0.06 0.09
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In brief, 20e28 h prior to aerosol fraction generation, cells were
trypsinized and resuspended in Dulbecco's modiﬁed Eagle's me-
dium supplemented with heat-inactivated fetal bovine serum (10%
v/v) (Thermo Fisher Scientiﬁc, Waltham, MA, USA), 4 mM L-gluta-
mine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. Subse-
quently, 4.75e5.25  103 viable cells were seeded in each well of a
96-well plate and cultured at 37 C (5% CO2 and 70% RH). Cells were
exposed to eight concentrations of each test substance for 23 ± 1 h
in 96-well plates with six wells used per concentration. The
exposure plates were sealed with a CO2-permeable plastic ﬁlm to
prevent potential carry-over of volatile substances. Following the
exposure phase, the cell culture medium was replaced with cell
culture medium containing neutral red dye at 50 mg/ml, and incu-
bated at 37 C (5% CO2 and 70% RH) for an additional 3 ± 0.5 h.
Subsequently, the cells were washed with PBS, and the neutral red
dye taken up by cells was extracted by the addition of destaining
solution (ethanol, water, and acetic acid, mixed in a 50:49:1 ratio).
The plates were mechanically shaken using a vibrating platform
shaker (Titramax 1000, Heidolph Instruments, Schwabach, Ger-
many) for 10 min at approximately 450 strokes/min. Neutral red
absorbance was measured at 540 nm with a microplate reader
(Saﬁre 2, Tecan GmbH, Gr€odig, Austria). The measured absorbance
for each concentration was normalized against the appropriate
solvent control and converted to a percentage value. Cytotoxicity
was expressed as 1/EC50, and expressed as a function of the mass of
TPM trapped on the Cambridge glass-ﬁber ﬁlter pads (TPM basis)
and on a per-mg nicotine basis. For consistency and to compare GVP
fractions, data were calculated and expressed on a per-mg TPM
basis and on a per-mg nicotine basis (Roemer et al., 2014). The EC50
endpoint measurement corresponds to the concentration of test
substance for which a decrease of 50% in the uptake of the neutral
red dye is observed, and was determined with the SAS® Enterprise
guide® 4.3 (SAS 9.2) software program (SAS, Cary, NC, USA).
The relationship between the concentration of the substance
and the decrease in the uptake of neutral red dye has a sigmoid
shape and is described by the Hill function, which is a four
parameter non-linear function. Statistical analysis was performed
using SAS. Unless mentioned otherwise in the text, all reagents
were obtained from SigmaeAldrich (St. Louis, MO, USA).
2.9.2. Ames assay
Mutagenic activity was evaluated by using the Salmonella
typhimurium tester strains TA98, TA100, TA102, TA1535, and
TA1537 with and without an S9 enzymatic metabolizing fraction,
by following a pre-incubation method (Maron and Ames, 1983) and
the OECD 471 test guideline (Organisation for Economic Co-
operation and Development, 1997). The S9 enzymatic metabo-
lizing fraction was obtained from Aroclor 1254-induced male
SpragueeDawley rat liver (Moltox, NC, USA). The TPM mainstream
smoke fraction from the 3R4F reference cigarette was generated
and tested in parallel with the THS2.2 aerosol fraction. The strains
were grown overnight in a shaking incubator at 37 C for approx-
imately 10 h in Oxoid Nutrient Broth No. 2 (Fisher Scientiﬁc,
Reinach, Switzerland). To determine mutagenic activity, seven
different concentrations of THS2.2 TPM diluted in DMSO were
tested. The bacteria (approximately 1  109 in 100 ml) were com-
bined with 50 ml of either the test item, the solvent, or the positive
control, and 500 ml of the cofactor buffer (pH 7.4) supplemented
with S9 as appropriate and pre-incubated at 37 C for 20 min prior
to adding 2 ml of histidine (50 mM ﬁnal concentration) supple-
mented soft top agar and plating the entire mixture onto histidine-
deﬁcient 90 mm minimal glucose agar base plates for 2 days at
37 C. Revertant colonies were counted using an automatic colony
counter (Sorcerer, Perceptive Instruments, Bury Saint Edmunds,UK). All experiments were performed in triplicate. Toxicity was
detected as either a reduction in the number of histidine revertants
or as a thinning of the auxotrophic background lawn. Themutagens
used as positive controls, i.e. substances known to induce a muta-
genic response to demonstrate the assay is working efﬁciently, in
experiments without the S9 mix were 4-nitrophenylenediamine
(10mg/plate) for TA98 and TA100, sodium azide (1.25mg/plate) for
TA1535 and TA1537, and cumene hydroperoxide (3mg/plate) for
TA102. In the experiments that included the S9 fraction, benzo[a]
pyrene (1 mg/plate) was used for TA98, and 2-aminoanthracene
(2.5mg/plate) was used for TA100, TA102, TA1535, and TA1537.
DMSO (50ml/plate) served as the solvent control. All positive con-
trol chemicals were obtained from either Sigma-Aldrich (St. Louis,
MO, USA) or Moltox (Boone, NC, USA). The biological activity after
1 mg of TPM exposure is reported as a means to permit a rapid
assessment of the impact of the 3R4F aerosol vs. the THS2.2 aerosol.
One milligram was the maximum dose tested of the 3R4F aerosol
(for toxicity reasons) and thus comparison at 5 mg or higher con-
centrations was not technically possible.
2.9.3. Mouse lymphoma assay (MLA)
The L5178Y tk ± cell line (sub-clone 3.7.2C (IVGT), Public Health
England, UK) was used in the MLA. Spontaneously-occurring tk/
mutants were purged from working stocks using methotrexate to
select against tk-deﬁcient cells and thymidine, hypoxanthine, and
guanine to ensure optimal growth of tk-proﬁcient cells as previ-
ously described (Chen and Moore, 2004). Cells were maintained in
RPMI 1640 medium (Thermo Fisher Scientiﬁc, Waltham, MA, USA)
supplemented with heat-inactivated horse serum (10% v/v)
(Thermo Fisher Scientiﬁc, Waltham, MA, USA), penicillin (200 U/
ml), streptomycin (200 mg/ml), L-glutamine (2 mM), sodium py-
ruvate (1 mM), and pluronic acid F68 (0.1% v/v) (SigmaeAldrich, St.
Louis, MO, USA). Short-term treatments (4 h) were carried out in
reduced serum medium (3% v/v), while 10% v/v-containing me-
dium was utilized for longer-term exposures (24 h). Cloning was
carried out in 20% v/v-containing serum medium in the absence of
pluronic acid F68. Aroclor 1254-induced male SpragueeDawley rat
liver S9 in 0.15 M KCl (Moltox, USA), in combination with a cofactor
mix of glucose-6-phosphate and nicotinamide adenine dinucleo-
tide phosphate (both from Roche Applied Science, Basel,
Switzerland), were used as the exogenous metabolic activation
system in the assay. The ﬁnal concentration of S9 in cell cultures
was 0.95 mg protein/ml (2% v/v). The controls used were methyl
methanesulfonate (15 and 20 mg/ml) for the 4 h S9- test arm,
methyl methanesulfonate (5 and 7.5 mg/ml) for the 24 h S9- arm,
and 7,12-dimethylbenz[a]anthracene (1 and 1.5 mg/ml) for the 4 h
S9þ arm.
The microwell version of the MLA was performed according to
the OECD TG 490 guideline (Organisation for Economic Co-
operation and Development, 2015). Brieﬂy, on two independent
test occasions, L5178Y cells in single replicate cultures were seeded
at a density of 5 105 or 2 105 cells/ml (at least 6 106 cells), and
exposed to 14 concentrations of TPM and GVP derived from THS2.2
and the 3R4F reference cigarette for 4 h in the presence (þS9) and
absence (-S9) of metabolic activation and 24 h in the absence of
metabolic activation (S9) treatment conditions, respectively. For
each treatment condition, cells were exposed for 4 or 24 h at 37 C
in the presence of 5% CO2 and RH  65%. Following treatment, cells
were washed and sub-cultured at a maximum density of
2 105 cells/ml (at most 6 106 cells) for two further days to allow
phenotypic expression of the tk gene prior to mutant selection.
Cells at 8 cells/ml or 1 104 cells/ml were then distributed into 96-
microwell plates (200 ml per well) to determine ﬁnal levels of TPM-
and GVP-induced cytotoxicity and mutagenicity, respectively.
Cytotoxicitywas determined from the relative total growth (RTG) of
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non-selective growth medium (typically 10e11 days). TPM- and
GVP-treated cell cultures which underwent excessive cytotoxicity
were discarded through the assay procedure as mutagenicity data
derived from these cells are difﬁcult to interpret because of their
questionable biological relevance. Tk mutants were detected
following culture in triﬂuorothymidine (TFT)-containing growth
medium (SigmaeAldrich, St. Louis, MO, USA) for typically 14 days.
Mutant colonies were enumerated visually; colonies with a size
less than a quarter of the microwell's surface area were deﬁned as
small colonies, while ones covering more than a quarter of the
microwell's surface area were deﬁned as large colonies. Mutation
frequencies were calculated according to published method
(Clements, 2000). The controls used were methyl methanesulfo-
nate (15 and 20 mg/ml) for the 4 h S9- test arm, methyl meth-
anesulfonate (5 and 7.5 mg/ml) for the 24 h S9- arm and ﬁnally 7,12-
dimethylbenz[a]anthracene (1 and 1.5 mg/ml) for the 4 h S9þ arm.
The data generated from solvent-treated and positive controls
in each treatment condition on the separate test occasions were
evaluated for acceptability according to OECD TG 490 guideline
(Organisation for Economic Co-operation and Development, 2015)
and the laboratory's historical control database. Furthermore, a
response to an aerosol fraction was considered positive, i.e.
mutagenic, in the MLA if there was a concentration-related in-
crease in mutation frequency (MF) with a corresponding RTG not
lower than 10%, and if an MF exceeded the sum of the microwell
global evaluation factor (GEF) of 126 plus the mean MF of the
solvent-treated controls (Moore et al., 2006, 2007). The microwell
GEF of 126 mutants per 106 viable cells was previously deﬁned as
the mean of the negative/solvent control MF distribution plus one
standard deviation in a multi-laboratory microwell MLA study
(Moore et al., 2006). Mutagenic potencies were evaluated using
the lowest observed genotoxic effect level (LOGEL) (Guo et al.,
2015). A LOGEL in this study was deﬁned as the lowest concen-
tration of TPM or GVP (expressed on a per-mg nicotine basis)
tested that induced a mutagenic response which exceeded the
GEF.
2.10. Statistical analyses
The results of the analyte quantiﬁcations are expressed in two
different ways: On a per-Tobacco Stick/cigarette basis, and on a per-
mg nicotine basis. For all analyte, the number of values (N), the
arithmetic mean (M), and the conﬁdence interval of the mean at
95% (CI95%) are given. For groups including at least one measured
value below the limit of quantiﬁcation (LOQ) of the analytical
method, only the median or the LOQ was given, depending on
whether the median was above or below the LOQ. The mean on a
per-mg nicotine basis and the respective conﬁdence interval of the
mean were calculated as follows:
M ¼ MðAÞ
MðBÞ
where A denotes the value of an analyte on a cigarette basis, and B
denotes the mean value for nicotine on a cigarette basis.
and
±CI95%

MðAÞ
MðBÞ

¼ ±tð0:975;N  1Þ*
MðAÞ
MðBÞ*
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S2MðAÞ
MðAÞ2 þ
S2MðBÞ
MðBÞ2
r
ﬃﬃﬃﬃ
N
p
where A denotes the mean of an analyte on a cigarette basis, B
denotes the mean for nicotine on a cigarette basis, S is the standard
deviation, N is the number of measurements, t(p,df) is thepercentile of Student's distribution, and df is degrees of freedom.
For the NRU assay, the cytoxicity (1/EC50) of the 3R4F reference
cigarette and the THS2.2 FR1 and THS2.2 FR1 M Tobacco Sticks,
expressed on a per-TPM basis and on a per-mg nicotine basis, was
compared using one-way analysis of variance followed by Dun-
nett's multiple comparison procedure, with the 3R4F reference
cigarette as the reference group. This statistical approach was used
because 2 THS2.2 test items were compared with 3R4F within one
study. However, the cytotoxicity of the THS2.2 D2 and THS2.2 D1 M
tobacco sticks was compared against the 3R4F reference cigarette
using Student's t-test. In this case the t-test was used because 2
studies were performed, each with one test item and the reference
cigarette 3R4F.
3. Results
3.1. Chemical composition of the THS2.2 aerosol, and comparison
with the mainstream smoke from the 3R4F reference cigarette
Two versions of the THS2.2 Regular (THS2.2 FR1 and THS2.2
D2) and two versions of the THS2.2 Menthol (THS2.2 FR1 M and
THS2.2 D1 M) were compared with the 3R4F reference cigarette
under HCI machine-smoking conditions. Fifty-nine analytes (60
for menthol products) were determined, covering various chemi-
cal classes present in different aerosol phases (Table 5 and
Table 6). Fifteen analytes in THS2.2 FR1 (benzo[a]pyrene, 3- and 4-
aminobiphenyl, quinoline, NAT, pyrene, nitrobenzene, vinyl chlo-
ride, dibenz[a,h]anthracene, and all the elements except mercury)
and 11 analytes in THS2.2 D2 (2-aminonaphthalene, 3- and 4-
aminobiphenyl, vinyl chloride, dibenz[a,h]anthracene, and all the
elements except mercury) were below the LOQ. In THS2.2 FR1 M,
the yields of 11 analytes (2-aminonaphthalene, 4-aminobiphenyl,
quinoline, NAT, all the elements except mercury and selenium,
vinyl chloride, and dibenz[a,h]anthracene and 8 analytes in the
THS2.2 D1 M (2-aminonaphthalene, 3-aminobiphenyl, arsenic,
cadmium, lead, selenium, vinyl chloride, and dibenz[a,h]anthra-
cene) were below the LOQ. The 54 HPHCs which were targets for
reduction (Section 1) were lower in the THS2.2 aerosol than in the
3R4F smoke. The yields of analytes expressed on a per-mg nicotine
basis are presented in Table A and in Table B of the supplementary
material.
The pie charts in Fig. 3 illustrates the differences in TPM
composition between the 3R4F and the THS2.2 FR1. While the
THS2.2 FR1 delivered about the same TPM yield as the 3R4F, the
THS2.2 aerosol composition was qualitatively and quantitatively
different from that of 3R4F. The quantities of water and glycerol
relative to total TPM were considerably higher for the THS2.2,
whereas the amount of nicotine was approximately 30% lower for
the THS2.2. Therefore, the relative yields of the ‘other’ aerosol
constituents were noticeably lower in the THS2.2 TPM. This is also
evident when comparing the color of the Cambridge glass-ﬁber
ﬁlter pads after collection of the same amount of aerosol mass
and TPM from THS2.2 tobacco sticks and 3R4F cigarettes, respec-
tively (Fig. 3). Previous heat-not-burn products such as Premier
(deBethizy et al., 1990) and Eclipse (Borgerding et al., 1998) also
produce TPM compositions that contained mainly water and glyc-
erin. Visually, the collected aerosol from THS2.2 on a Cambridge
glass-ﬁber ﬁlter pad appears similar to that seen for both Premier
and Eclipse.
3.2. Chemistry of the THS2.2 aerosol generated under different
climatic conditions
The three climatic conditions, “Mediterranean”, “desert“, and
“tropical“, were selected according to ICH (International Council
Table 5
Analyte yields from THS2.2 FR1, THS2.2 FR1 M, and 3R4F obtained under HCI machine-smoking conditions and expressed on a per-cigarette/tobacco stick basis.
Parameter Unit THS2.2 FR1 THS2.2 FR1 M 3R4F
Mean ± CI95% N Mean ± CI95% N Mean ± CI95% N
TPM mg/stick 48.2 ± 2.4 4 43.5 ± 1.5 4 49.0 ± 4.8 4
Water mg/stick 36.5 ± 3.1 4 29.7 ± 3.6 4 15.8 ± 2.9 4
Nicotine mg/stick 1.32 ± 0.16 4 1.21 ± 0.09 4 1.89 ± 0.16 4
NFDPM mg/stick 10.3 ± 0.9 4 12.6 ± 2.2 4 31.2 ± 1.8 4
Carbon monoxide mg/stick 0.531 ± 0.068 4 0.594 ± 0.110 4 32.8 ± 2.4 4
Benzo[a]pyrene ng/stick <1.00 4 1.29 ± 0.10 4 14.2 ± 0.3 4
Puff Count /stick 12 ± 0 4 12 ± 0 4 10.6 ± 0.4 4
Menthol mg/stick n.a. 2.62 ± 0.1 4 n.a.
Glycerin mg/stick 4.63 ± 0.83 4 3.94 ± 0.87 4 2.42 ± 0.14 4
1-aminonaphthalene ng/stick 0.077 4 0.086 4 20.8 ± 1.3 4
2-aminonaphthalene ng/stick 0.046 ± 0.008 4 <0.035 4 11.0 ± 0.6 4
3-aminobiphenyl ng/stick <0.032 4 0.032 4 3.77 ± 0.47 4
4-aminobiphenyl ng/stick <0.051 4 <0.051 4 3.26 ± 0.12 4
Acetaldehyde mg/stick 219 ± 31 4 205 ± 12 4 1555 ± 184 4
Acetone mg/stick 40.7 ± 6.2 4 39.4 ± 2.3 4 736 ± 129 4
Acrolein mg/stick 11.30 ± 2.36 4 9.15 ± 0.43 4 154 ± 20 4
Butyraldehyde mg/stick 26.1 ± 2.3 4 26.7 ± 2 4 88.4 ± 10.7 4
Crotonaldehyde mg/stick 4.14 ± 0.23 4 3.24 ± 0.21 4 68.8 ± 14.4 4
Formaldehyde mg/stick 5.53 ± 0.69 4 4.55 ± 0.25 4 56.5 ± 12.1 4
Methyl ethyl ketone mg/stick 7.18 ± 1.19 4 6.93 ± 0.64 4 187 ± 30 4
Propionaldehyde mg/stick 14.5 ± 2.4 4 13.9 ± 0.7 4 125 ± 16 4
Acrylonitrile mg/stick 0.258 ± 0.041 4 0.220 ± 0.014 4 31.9 ± 1.8 4
1,3-butadiene mg/stick 0.294 ± 0.042 4 0.265 ± 0.024 4 63.8 ± 3.5 4
Benzene mg/stick 0.649 ± 0.074 4 0.640 ± 0.040 4 97.6 ± 4.7 4
Isoprene mg/stick 2.35 ± 0.39 4 2.11 ± 0.18 4 798 ± 49 4
Pyridine mg/stick 7.54 ± 0.26 4 7.21 ± 0.25 4 36.1 ± 2.2 4
Quinoline mg/stick <0.012 4 <0.012 4 0.513 ± 0.023 4
Styrene mg/stick 0.608 ± 0.058 4 0.561 ± 0.033 4 24.5 ± 1.2 4
Toluene mg/stick 2.59 ± 0.43 4 2.39 ± 0.16 4 188 ± 11 4
Catechol mg/stick 16.3 ± 1.5 4 17.1 ± 1.1 4 91.4 ± 5.6 4
o-cresol mg/stick 0.069 ± 0.008 4 0.095 ± 0.025 4 4.47 ± 0.16 4
m-cresol mg/stick 0.029 ± 0.004 4 0.033 ± 0.006 4 3.03 ± 0.08 4
p-cresol mg/stick 0.072 ± 0.008 4 0.083 ± 0.010 4 9.17 ± 0.44 4
Hydroquinone mg/stick 8.10 ± 0.48 4 8.98 ± 1.02 4 83.1 ± 5.5 4
Phenol mg/stick 1.16 ± 0.12 4 1.60 ± 0.4 4 13.6 ± 0.9 4
Resorcinol mg/stick 0.041 ± 0.003 4 0.048 ± 0.004 4 1.85 ± 0.08 4
NAB ng/stick <3.15 4 <3.15 4 33.7 ± 8.5 4
NAT ng/stick 20.5 ± 0.5 4 19.7 ± 3.6 4 318 ± 74 4
NNK ng/stick 6.7 ± 0.6 4 5.9 ± 0.4 4 266 ± 15 4
NNN ng/stick 17.2 ± 1.25 4 13.7 ± 1.21 4 309 ± 41 4
Ammonia mg/stick 14.2 ± 1.1 4 13.8 ± 0.7 4 39.3 ± 3.2 4
Hydrogen cyanide mg/stick 4.81 ± 0.35 4 5.14 ± 0.70 4 493 ± 78 4
Nitric oxide mg/stick 16.8 ± 2.3 4 12.3 ± 1.7 4 491 ± 38 4
Nitrogen oxides mg/stick 17.3 ± 2.6 4 12.6 ± 1.7 4 537 ± 43 4
Arsenic ng/stick <1.13 4 <1.13 4 8.51 ± 0.34 4
Cadmium ng/stick <0.350 4 <0.350 4 161 ± 4 4
Chromium ng/stick <0.55 4 <0.55 4 <0.55 4
Lead ng/stick <3.35 4 <3.35 4 37.0 ± 0.7 4
Mercury ng/stick 1.17 ± 0.05 4 1.34 ± 0.18 4 4.80 ± 0.13 4
Nickel ng/stick <0.55 4 <0.55 4 <0.55 4
Selenium ng/stick <0.550 2 0.780 4 1.62 ± 0.32 4
Pyrene ng/stick <5.00 4 9.06 ± 0.68 4 87.3 ± 2.5 4
o-toluidine ng/stick 1.260 ± 0.187 4 0.777 ± 0.287 4 85.5 ± 2.7 4
Acetamide mg/stick 4.02 ± 0.18 4 4.30 ± 0.24 4 13.9 ± 0.5 4
Acrylamide mg/stick 1.73 ± 0.12 4 1.91 ± 0.16 4 4.8 ± 0.3 4
Ethylene oxide mg/stick 0.201 ± 0.014 4 0.202 ± 0.013 4 29.4 ± 2.0 4
Nitrobenzene ng/stick <0.188 4 0.335 ± 0.164 4 8.62 ± 1.10 4
Propylene oxide mg/stick 0.148 ± 0.018 4 0.149 ± 0.017 4 1.32 ± 0.12 4
Vinyl chloride ng/stick <3.54 4 <3.54 4 96.7 ± 2.0 4
Benz[a]anthracene ng/stick 1.45 ± 0.14 4 2.49 ± 0.17 4 28.0 ± 0.6 4
Dibenz[a,h]anthracene ng/stick <0.100 4 <0.100 4 1.70 ± 0.11 4
N is the number of determinations, CI is the conﬁdence interval of the mean, n.a.: not analyzed.
<: median lower than the limit of quantitation, in this case LOQ is given.
If at least one value is below the LOQ, the median is given and the CI is not mentioned.
TPM: Total particulate matter, NFDPM: Nicotine-free dry particulate matter, NAB: N-nitrosoanabasine, NAT: N-nitrosoanatabine, NNK: 4-(N-nitrosomethylamino)-1-(3-
pyridyl)-1-butanone, NNN: N-nitrosonornicotine.
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Table 6
Analytes yields from THS2.2 D2, THS2.2 D1 M, and 3R4F obtained under HCI machine-smoking conditions and expressed on a per-cigarette/tobacco stick basis.
Parameter Unit THS2.2 D2 THS2.2 D1 M 3R4F
mean ± CI95% N mean ± CI95% N mean ± CI95% N
TPM mg/stick 54.1 ± 2.4 4 53.8 ± 3.6 4 46.3 ± 2.9 4
Water mg/stick 39.4 ± 4.6 4 39.1 ± 3.6 4 13.3 ± 1.6 4
Nicotine mg/stick 1.26 ± 0.24 4 1.32 ± 0.11 4 2.09 ± 0.14 4
NFDPM mg/stick 13.4 ± 2.8 4 13.4 ± 0.6 4 30.9 ± 1.9 4
Carbon monoxide mg/stick 0.598 ± 0.072 4 0.620 ± 0 4 30.7 ± 3.0 4
Benzo[a]pyrene ng/stick 1.19 ± 0.08 4 1.08 ± 0.09 3 13.7 ± 0.8 4
Puff Count /stick 12 ± 0 4 12 ± 0 4 10.7 ± 0.7 4
Menthol mg/stick n.a. 2.98 ± 0.21 4 n.a.
Glycerin mg/stick 4.1 ± 1.07 4 4.59 ± 0.47 4 2.39 ± 0.15 4
1-aminonaphthalene ng/stick 0.063 ± 0.006 4 <0.061 4 19.7 ± 1.6 4
2-aminonaphthalene ng/stick <0.035 4 <0.035 4 14.8 ± 1.9 4
3-aminobiphenyl ng/stick <0.013 4 <0.013 4 3.90 ± 0.42 4
4-aminobiphenyl ng/stick <0.021 4 n.a. 3.13 ± 0.60 4
Acetaldehyde mg/stick 213 ± 19 4 220 ± 22 4 1589 ± 76 4
Acetone mg/stick 33.8 ± 6.4 4 42.6 ± 8.1 4 729 ± 36 4
Acrolein mg/stick 9.44 ± 0.87 4 10.91 ± 2.98 4 193 ± 21 4
Butyraldehyde mg/stick 25.3 ± 2.7 4 26.4 ± 0.9 4 103.9 ± 8.3 4
Crotonaldehyde mg/stick 3.75 ± 0.34 4 4.15 ± 0.64 4 92.1 ± 13.2 4
Formaldehyde mg/stick 5.22 ± 0.24 4 6.19 ± 2.00 4 68.7 ± 7.8 4
Methyl ethyl ketone mg/stick 7.94 ± 0.75 4 10.19 ± 2.23 4 241 ± 16 4
Propionaldehyde mg/stick 13.6 ± 1.5 4 15.9 ± 2.2 4 147 ± 8 4
Acrylonitrile mg/stick 0.186 ± 0.028 4 0.196 ± 0.016 4 31.6 ± 2.3 4
1,3-butadiene mg/stick 0.319 ± 0.073 4 0.411 ± 0.093 4 91.8 ± 11.0 4
Benzene mg/stick 0.575 ± 0.072 4 0.628 ± 0.073 4 100.4 ± 2.8 4
Isoprene mg/stick 2.44 ± 0.50 4 2.63 ± 0.60 4 869 ± 50 4
Pyridine mg/stick 9.38 ± 0.95 4 10.08 ± 0.46 4 51.8 ± 7.5 4
Quinoline mg/stick 0.014 ± 0.002 4 0.010 ± 0.003 4 0.390 ± 0.101 4
Styrene mg/stick 0.672 ± 0.063 4 0.632 ± 0.079 4 28.9 ± 2.2 4
Toluene mg/stick 1.61 ± 0.17 4 1.67 ± 0.37 4 198.8 ± 10.9 4
Catechol mg/stick 16.4 ± 0.6 4 12.8 ± 1.3 4 88.7 ± 2.6 4
o-cresol mg/stick 0.105 ± 0.017 4 0.059 ± 0.007 4 4.86 ± 0.50 4
m-cresol mg/stick 0.042 ± 0.006 4 0.032 ± 0.005 4 3.71 ± 0.34 4
p-cresol mg/stick 0.073 ± 0.009 4 0.042 ± 0.007 4 8.50 ± 0.78 4
Hydroquinone mg/stick 7.86 ± 0.63 4 6.21 ± 0.86 4 84.1 ± 3.3 4
Phenol mg/stick 1.51 ± 0.23 4 1.00 ± 0.17 4 13.2 ± 0.9 4
Resorcinol mg/stick 0.055 ± 0.013 4 0.036 ± 0.005 4 1.95 ± 0.55 4
NAB ng/stick 3.52 ± 0.48 4 3.27 ± 0.15 4 34.1 ± 3.0 4
NAT ng/stick 22.3 ± 1.6 4 18.6 ± 2.9 4 300 ± 53 4
NNK ng/stick 10.1 ± 0.4 4 7.9 ± 1.1 4 257 ± 39 4
NNN ng/stick 10.3 ± 0.4 4 7.7 ± 1.0 4 268 ± 50 4
Ammonia mg/stick 15.6 ± 1.1 4 13.9 ± 1.1 4 39.2 ± 4.1 4
Hydrogen cyanide mg/stick 3.78 ± 0.44 4 5.57 ± 0.35 4 451 ± 47 4
Nitric oxide mg/stick 21.0 ± 8.1 3 18.4 ± 3.6 4 501 ± 33 3
Nitrogen oxides mg/stick 22.6 ± 8.8 3 19.4 ± 4.0 4 541 ± 74 3
Arsenic ng/stick <1.13 4 <1.13 4 6.56 ± 0.46 4
Cadmium ng/stick <0.350 4 <0.350 4 122 ± 12 4
Chromium ng/stick <0.17 4 0.44 4 2.70a 2
Lead ng/stick <3.35 4 <3.35 4 25.1 ± 2.1 4
Mercury ng/stick 1.02 ± 0.05 4 1.12 ± 0.19 4 4.17 ± 0.74 4
Nickel ng/stick <0.55 4 0.88 4 1.30a 2
Selenium ng/stick <0.550 4 <0.550 4 1.43 ± 0.15 4
Pyrene ng/stick 7.93 ± 0.78 4 7.71 ± 0.63 3 87.3 ± 4.1 4
o-toluidine ng/stick 1.204 ± 0.149 4 0.868 ± 0.087 4 90.5 ± 3.1 4
Acetamide mg/stick 4.13 ± 0.21 4 3.43 ± 0.17 4 13.7 ± 0.7 4
Acrylamide mg/stick 2.27 ± 0.28 4 1.90 ± 0.12 4 5.3 ± 0.4 4
Ethylene oxide mg/stick 0.314 ± 0.011 4 0.273 ± 0.036 4 34.2 ± 3.6 4
Nitrobenzene ng/stick 0.092 ± 0.008 4 0.155 ± 0.004 8 0.55 ± 0.04 4
Propylene oxide mg/stick 0.175 ± 0.03 4 0.14 ± 0.019 4 1.72 ± 0.16 4
Vinyl chloride ng/stick <3.47 4 <3.47 4 95.3 ± 12.3 4
Benz[a]anthracene ng/stick 2.58 ± 0.17 4 2.50 ± 0.06 3 26.6 ± 1.7 4
Dibenz[a,h]anthracene ng/stick <0.100 4 <0.100 4 1.79 ± 0.14 4
N is the number of determinations, CI is the conﬁdence interval of the mean, n.a.: not analyzed.
<: median lower than the limit of quantitation, in this case LOQ is given.
If at least one value is below the LOQ, the median is given and the CI is not mentioned.
TPM: Total particulate matter, NFDPM: Nicotine-free dry particulate matter, NAB: N-nitrosoanabasine, NAT: N-nitrosoanatabine, NNK: 4-(N-nitrosomethylamino)-1-(3-
pyridyl)-1-butanone, NNN: N-nitrosonornicotine.
a CI not calculated.
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Fig. 3. Cigarette total particulate matter (TPM) compared with THS2.2 aerosol composition generated according to the HCI machine-smoking conditions for measuring emissions.
The photographs of the Cambridge glass-ﬁber ﬁlter pads after the collection of cigarette smoke (left) and THS2.2 aerosol (right) are also shown.
J.-P. Schaller et al. / Regulatory Toxicology and Pharmacology 81 (2016) S27eS47 S37for Harmonisation, 2003) and WHO (World Health Organisation
Technical Report, 2015) guidelines for stability testing.
Since the generation of HPHCs either through pyrosynthesis or
distillation should be enhanced when increasing the tempera-
ture, lower temperatures were not considered for this compari-
son. The impact of temperature and relative humidity (RH)
on the deliveries of the different analytes in the THS2.2 FR1
aerosol is presented in Table 7. The data expressed on a per-mg
nicotine basis are presented in Table C of the supplementary
material.3.3. Aerosol chemistry of the THS2.2 FR1 generated with different
machine-smoking regimens
The range of machine-smoking regimens used during this test
was quite broad, and ranged from a total puff volume of 210 ml for
the ISO conditions to 1120 ml for the LR-3 regimen (see Table 2).
Despite these substantial differences in puff volumes, benzo[a]
pyrene, 1-aminonaphthalene, 2-aminonaphthalene, 3-aminobi-
phenyl, 4-aminobiphenyl, dibenz[a,h]anthracene, and vinyl chlo-
ride remained below the LOQ for all machine-smoking regimens.
For the other analytes, ISO and SR-1 delivered the lowest yields of
HPHCs, while machine-smoking regimens SR-4, SR-6, and LR-3
delivered the highest HPHC yields. A summary of the obtained
results is presented in Table 8 together with the yields obtained for
the 3R4F reference cigarette smoked in the HCI conditions. All the
individual results are presented in Tables D and E of the
supplementary material.
The LR-3 smoking regimen could not be performed with the
Borgwaldt linear smoking machine type used to quantify NO and
NOx. Therefore, this value was not reported. For TPM and carbonyls,the breakthrough was speciﬁcally tested with the most intense
smoking regimens to ensure that losses were negligible and did not
affect the accuracy of the measurements.
3.4. Physical measurement of the aerosol
Ten series of measurement were performed on the 3R4F
reference cigarette and on the THS2.2 FR1. All the calculated
MMAD, GSD, and boundary values are presented in Table 9.
The upper boundaries (UB) were below 2.5 mm. Consequently,
the smoke generated from the 3R4F and the aerosol generated
from the THS2.2 were respirable for all replicates with a
margin of error of 5% and, according to Hinds (Hinds, 1999), more
than 85% of the aerosol droplets could reach the alveoli in the
lung.
3.5. Neutral red uptake (NRU) assay
Two versions of the THS2.2 Regular (THS2,2 FR1 and THS2.2 D2)
and two versions of the THS2.2 Menthol (THS2.2 FR1 M and THS2.2
D1 M) were tested and compared with the 3R4F under HCI
machine-smoking conditions in the NRU assay in independent
studies. The cytotoxic activity of both the TPM and GVP fractions
from the THS2.2 and the 3R4F reference cigarette was determined.
A clear concentration-dependent decrease in the number of viable
cells was observed for the aerosol fractions generated from the
THS2.2 Regular (FR1 and D2) and THS2.2. Menthol (FR1 and D1)
and the smoke fractions generated from the 3R4F reference ciga-
rette. The cytotoxicity levels induced by both products covered a
range spanning from no or low to high cytotoxicity. The 1/EC50
values (expressed on a per-mg TPM basis and on a per-mg nicotine
Table 7
Yields on tobacco stick basis from THS2.2 FR1 obtained under three climatic conditions.
Parameter Unit Mediterranean 22 C, 60% RH Desert 30 C, 35% RH Tropical 30 C, 75% RH Rangea
mean ± CI95% N mean ± CI95% N mean ± CI95% N
TPM mg/stick 47.1 ± 2.0 5 27.9 ± 1.4 5 65.1 ± 4.5 5 37.2
Water mg/stick 33.5 ± 1.5 5 15.1 ± 0.4 5 50.6 ± 3.7 5 35.5
Nicotine mg/stick 1.42 ± 0.05 5 1.46 ± 0.05 5 1.21 ± 0.02 5 0.25b
NFDPM mg/stick 12.2 ± 1.1 5 11.3 ± 1.4 5 12.6 ± 1.5 5 1.3
Carbon monoxide mg/stick 0.612 ± 0.020 5 0.454 ± 0.047 5 0.468 ± 0.024 5 0.158
Benzo[a]pyrene ng/stick <1.00 5 1.03 5 <1.00 5
Glycerin mg/stick 4.68 ± 0.36 5 4.25 ± 0.25 5 4.23 ± 0.09 5 0.45b
1-aminonaphthalene ng/stick <0.069 5 <0.069 5 <0.069 5
2-aminonaphthalene ng/stick <0.035 5 <0.035 5 0.088 ± 0.173 5
3-aminobiphenyl ng/stick <0.032 5 <0.032 5 <0.032 5
4-aminobiphenyl ng/stick <0.051 5 <0.051 5 0.073 ± 0.022 5
Acetaldehyde mg/stick 193 ± 2 5 179 ± 11 5 229 ± 5 5 50
Acetone mg/stick 37.7 ± 1.7 5 37.0 ± 5.5 5 43.0 ± 2.9 5 6.0
Acrolein mg/stick 9.76 ± 0.91 5 8.87 ± 1.81 5 11.54 ± 0.81 5 2.67
Butyraldehyde mg/stick 27.3 ± 0.7 5 26.0 ± 0.5 5 29.9 ± 2 5 3.9
Crotonaldehyde mg/stick 4.13 ± 0.55 5 3.69 ± 0.51 5 4.64 ± 0.41 5 0.95
Formaldehyde mg/stick 3.52 ± 0.3 5 3.65 ± 0.36 5 3.57 ± 0.3 5 0.13b
Methyl ethyl ketone mg/stick 7.58 ± 0.71 5 6.75 ± 0.84 5 8.68 ± 0.57 5 1.93b
Propionaldehyde mg/stick 14.4 ± 0.6 5 13.5 ± 2.1 5 18.1 ± 0.7 5 4.6
Acrylonitrile mg/stick 0.167 ± 0.036 5 0.178 ± 0.021 5 0.189 ± 0.035 5 0.022b
1,3-butadiene mg/stick 0.277 ± 0.035 5 0.248 ± 0.016 5 0.318 ± 0.027 5 0.070b
Benzene mg/stick 0.603 ± 0.042 5 0.591 ± 0.031 5 0.613 ± 0.030 5 0.022b
Isoprene mg/stick 2.19 ± 0.21 5 1.83 ± 0.17 5 2.60 ± 0.25 5 0.77
Pyridine mg/stick 7.47 ± 0.31 5 5.76 ± 0.42 5 7.26 ± 0.29 5 1.71
Quinoline mg/stick <0.012 5 <0.012 5 <0.012 5
Styrene mg/stick 0.640 ± 0.035 5 0.619 ± 0.041 5 0.695 ± 0.038 5 0.076b
Toluene mg/stick 2.11 ± 0.2 5 1.85 ± 0.15 5 2.25 ± 0.19 5 0.4b
Catechol mg/stick 16.9 ± 1.2 5 15.0 ± 2.0 5 15.2 ± 1.4 5 1.9
o-cresol mg/stick 0.109 ± 0.006 4 0.123 ± 0.021 5 0.135 ± 0.017 5 0.026b
m-cresol mg/stick 0.031 ± 0.003 4 0.061 ± 0.01 5 0.071 ± 0.029 5 0.040
p-cresol mg/stick 0.070 ± 0.006 4 0.099 ± 0.019 5 0.099 ± 0.012 5 0.029b
Hydroquinone mg/stick 8.51 ± 0.63 5 7.11 ± 1.17 5 8.21 ± 0.25 5 1.40
Phenol mg/stick 1.66 ± 0.36 5 2.49 ± 0.45 5 2.23 ± 0.26 5 0.83
Resorcinol mg/stick 0.054 ± 0.004 5 0.047 ± 0.007 5 0.044 ± 0.005 5 0.01
NAB ng/stick 3.37 ± 0.21 4 <3.15 5 <3.15 5
NAT ng/stick 21.7 ± 1.4 4 20.1 ± 1.7 5 17.0 ± 0.6 5 4.7
NNK ng/stick 9.2 ± 0.3 4 8.3 ± 1 5 7.7 ± 1.2 5 1.5
NNN ng/stick 16.4 ± 1.3 4 14.6 ± 1.6 5 13.9 ± 0.8 5 2.5b
Ammonia mg/stick 14.6 ± 0.4 5 15.4 ± 0.2 5 15.3 ± 0.9 5 0.8b
Hydrogen cyanide mg/stick 4.84 ± 0.29 4 4.14 ± 0.32 5 4.39 ± 0.68 5 0.70b
Nitric oxide mg/stick 18.3 ± 1.2 5 16.6 ± 0.3 4 18.2 ± 0.2 4 1.7
Nitrogen oxides mg/stick 19.5 ± 1.5 5 17.6 ± 0.2 4 19.0 ± 0.6 4 1.9
Pyrene ng/stick 5.66 ± 0.61 5 7.27 ± 1.63 5 5.85 ± 1.27 5 1.61
o-toluidine ng/stick 1.144 ± 0.113 5 0.649 ± 0.318 5 0.62 ± 0.59 5 0.524
Acetamide mg/stick 4.24 ± 0.13 4 4.28 ± 0.55 5 4.19 ± 0.16 5 0.09b
Acrylamide mg/stick 2.31 ± 0.12 5 2.30 ± 0.31 5 1.94 ± 0.05 5 0.37
Ethylene oxide mg/stick 0.267 ± 0.017 5 0.269 ± 0.012 5 0.355 ± 0.032 5 0.088
Nitrobenzene ng/stick 0.138 ± 0.003 4 0.087 ± 0.005 5 0.087 ± 0.009 5 0.051
Propylene oxide mg/stick 0.144 ± 0.01 5 0.101 ± 0.004 5 0.113 ± 0.009 5 0.043
Vinyl chloride ng/stick <3.54 5 <3.54 5 <3.54 5
Benz[a]anthracene ng/stick 1.39 ± 0.1 5 1.51 ± 0.35 5 1.39 ± 0.2 5 0.12
Dibenz[a,h]anthracene ng/stick <0.100 5 <0.100 5 <0.100 5
N is the number of determinations, CI is the conﬁdence interval of the mean.
<: median lower than the limit of quantitation, in this case LOQ is given.
If at least 1 value is below LOQ, the median is given and CI is not mentioned.
TPM: Total particulate matter, NFDPM: Nicotine-free dry particulate matter, NAB: N-nitrosoanabasine, NAT: N-nitrosoanatabine, NNK: 4-(N-nitrosomethylamino)-1-(3-
pyridyl)-1-butanone, NNN: N-nitrosonornicotine.
a Range: largest mean obtained among the three climatic conditions minus the smallest mean obtained among the three climatic conditions.
b Range smaller than the Intermediate Precision (IP) (International Council for Harmonisation, 1996) of the analytical method.
J.-P. Schaller et al. / Regulatory Toxicology and Pharmacology 81 (2016) S27eS47S38basis) were used to compare the relative cytotoxicity of the THS2.2
and the 3R4F reference cigarette. The results showed that the
relative in vitro cytotoxicity of the THS2.2 Regular (FR1 and D2) and
Menthol (FR1 and D1) aerosol fractions was reduced by approxi-
mately 95%when expressed on a per-mg TPM basis, compared withthe 3R4F reference cigarette (Tables F and G of the supplementary
material). The in vitro cytotoxicity of THS2.2 Regular (FR1 and D2)
and THS2.2 Menthol (FR1 and D1) aerosol fractions, expressed on a
per-mg nicotine basis, was reduced by 85e90% compared with the
3R4F reference cigarette (Table 10 and Table 11).
Table 8
Summary of the THS2.2 FR1 yields from extreme pufﬁng regimens; comparison with the Health Canada machine-smoking regimen and the 3R4F reference cigarette.
Parameter Unit THS2.2 FR1 THS2.2 FR1 THS2.2 FR1 3R4F
Extreme Regimen Maximum Yields Extreme Regimen Minimum Yields HCI Regimen Ratiob HCI regimen
mean puf. reg. mean puf. reg. mean Max/HCI mean
TPM mg/stick 59.0 SR-4 26.9 ISO 56.8 1.0 49.0
Water mg/stick 45.1 SR-4 21.4 ISO 44.6 1.0 15.8
Nicotine mg/stick 2.19 LR-3 0.49 ISO 1.36 1.6 1.89
NFDPM mg/stick 17.4 LR-3 5.1 ISO 10.8 1.6 31.2
Carbon monoxide mg/stick 0.660 SR-6 0.238 ISO 0.532 1.2 32.8
Benzo[a]pyrene ng/stick <1.00 <1.00 <1.00 14.2
Glycerin mg/stick 5.66 LR-3 1.91 ISO 4.59 1.2 2.42
1-aminonaphthalene ng/stick <0.069 <0.069 <0.069 20.8
2-aminonaphthalene ng/stick <0.035 <0.035 <0.035 11.0
3-aminobiphenyl ng/stick <0.032 <0.032 <0.032 3.77
4-aminobiphenyl ng/stick <0.051 <0.051 <0.051 3.26
Acetaldehyde mg/stick 205 SR-4 145 SR-1 196 1.0 1555
Acetone mg/stick 40.7 SR-4 22.0 SR-1 37.9 1.1 736
Acrolein mg/stick 12.9 LR-3 4.89 ISO 8.83 1.5 154
Butyraldehyde mg/stick 26.7 SR-6 16.7 ISO 22.0 1.2 88.4
Crotonaldehyde mg/stick 4.90 LR-3 1.88 ISO 3.04 1.6 68.8
Formaldehyde mg/stick 7.73 LR-3 1.85 ISO 3.77 2.1 56.5
Methyl ethyl ketone mg/stick 7.39 SR-4 3.78 SR-1 7.28 1.0 187
Propionaldehyde mg/stick 14.4 SR-4 8.5 SR-1 13.5 1.1 125
Acrylonitrile mg/stick 0.228 LR-3 <0.111 SR-1a 0.163 1.4 31.9
1,3-butadiene mg/stick 0.357 SR-4 <0.236 ISOa 0.295 1.2 63.8
Benzene mg/stick 0.708 SR-4 0.298 SR-1 0.597 1.2 97.6
Isoprene mg/stick 2.82 SR-5 1.37 SR-1 2.56 1.1 798
Pyridine mg/stick 8.00 SR-4 4.21 ISO 7.36 1.1 36.1
Quinoline mg/stick 0.051 LR-3 <0.011 ISOa 0.016 3.2 0.513
Styrene mg/stick 0.686 SR-6 0.314 SR-1 0.619 1.1 24.5
Toluene mg/stick 2.15 LR-3 0.97 ISO 2.02 1.1 188
Catechol mg/stick 17.9 SR-4 5.9 ISO 16.8 1.1 91.4
o-cresol mg/stick 0.438 LR-3 0.021 ISO 0.108 4.1 4.47
m-cresol mg/stick 0.212 LR-3 <0.010 ISOa 0.046 4.6 3.03
p-cresol mg/stick 0.399 LR-3 <0.010 SR-1 0.100 4.0 9.17
Hydroquinone mg/stick 9.99 SR-6 3.66 SR-1 8.76 1.1 83.1
Phenol mg/stick 10.87 LR-3 0.06 ISO 1.93 5.6 13.6
Resorcinol mg/stick 0.056 SR-6 0.020 ISO 0.047 1.2 1.85
NAB ng/stick 4.31 LR-3 <3.15 ISOa 3.46 1.2 33.7
NAT ng/stick 26.8 SR-6 8.5 ISO 22.4 1.2 318
NNK ng/stick 10.2 SR-6 4.1 ISO 8.7 1.2 266
NNN ng/stick 19.1 LR-3 6.5 ISO 16.1 1.2 309
Ammonia mg/stick 31 LR-3 4.1 ISO 15 2.1 39.3
Nitric oxide mg/stick 19.4 SR-4 11 ISO 18 1.1 491
Nitrogen oxides mg/stick 20.3 SR-4 11.2 ISO 19 1.1 537
Pyrene ng/stick 6.50 SR-4 <5.00 ISOa <5.00 87.3
o-toluidine ng/stick 2.146 SR-6 0.489 SR-1 1.195 1.8 85.5
Acetamide mg/stick 6.62 LR-3 1.32 ISO 4.18 1.6 13.9
Acrylamide mg/stick 4.23 LR-3 0.69 ISO 2.33 1.8 4.8
Ethylene oxide mg/stick 0.323 LR-3 0.157 SR-1 0.242 1.3 29.4
Vinyl chloride ng/stick <3.54 <3.54 <3.54 96.7
Benz[a]anthracene ng/stick 1.61 SR-4 <1.00 ISOa <1.00 28.0
Dibenz[a,h]anthracene ng/stick <0.100 <0.100 <0.100 1.7
<: median lower than the limit of quantitation, in this case LOQ is given.
TPM: Total particulate matter, NFDPM: Nicotine-free dry particulate matter, NAB: N-nitrosoanabasine, NAT: N-nitrosoanatabine, NNK: 4-(N-nitrosomethylamino)-1-(3-
pyridyl)-1-butanone, NNN: N-nitrosonornicotine.
a At least one other smoking regimen was also below LOQ; see Tables D a in the supplementary material.
b When the, minimum value was inferior to the LOQ, the LOQ value was used to calculate the ratios.
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The TPM from the THS2.2 D2, THS2.2 D1 M, and the 3R4F was
tested with the S. typhimurium strains TA98, TA100, TA102, TA1535,
and TA1537 in both the presence and absence of S9 (Table 12).
A positive response in the Ames test for the TPM from the 3R4F
reference cigarette was detected in 3 of the 5 S. typhimurium tester
strains in the presence of the S9 fraction, namely TA98, TA100, andTA1537 (see Table 12). Nevertheless, despite testing up to 10 mg of
TPM for THS2.2 D2 and 5 mg/per plate for THS2.2 D1 M, no
mutagenicity in any of the tester strains was detected under the
conditions of this assay.
3.7. Mouse lymphoma assay (MLA)
The in vitro MLA was used to assess the mutagenicity of both
Table 9
MMAD and GSD results from 3R4F and THS2.2 FR1.
Repetition 3R4F THS2.2 FR1
MMAD GSD2 LB UB MMAD GSD2 LB UB
[mm] [mm] [mm] [mm] [mm] [mm]
1 0.9 2.1 0.4 1.8 0.8 2.6 0.3 2.1
2 0.8 1.9 0.4 1.5 0.7 2.3 0.3 1.7
3 0.8 1.9 0.4 1.5 0.7 2.1 0.3 1.4
4 0.9 1.7 0.5 1.5 0.7 1.9 0.4 1.3
5 0.9 1.6 0.5 1.4 0.7 2.0 0.3 1.3
6 0.8 1.9 0.4 1.5 0.7 2.2 0.3 1.6
7 0.9 1.9 0.5 1.6 0.8 2.5 0.3 1.9
8 0.6 1.4 0.5 0.9 0.6 2.3 0.3 1.3
9 0.8 1.8 0.5 1.5 0.6 2.3 0.3 1.5
10 0.7 1.8 0.4 1.3 0.7 3.2 0.2 2.3
Mean 0.8 1.8 0.7 2.3
Mean GSD 1.3 1.5
MMAD: Mass median aerodynamic diameter; GSD: Geometric standard deviation.
LB: Lower boundaries with a 95% conﬁdence interval; UB: Upper boundaries with a
95% conﬁdence interval.
Table 11
Cytotoxicity of TPM and GVP, expressed as 1/EC50 (ml/mg nicotine).
THS2.2 FR1 THS2.2 FR1 M 3R4F
TPM GVP TPM GVP TPM GVP
Mean 21.33 30.86 27.43 28.61 186.78 242.01
SEM 1.57 2.87 1.6 2.53 7.58 14.06
N 3 3 3 3 3 3
Relative cytotoxicity (%) 11.4 12.8 14.7 11.8 100 100
SEM: Standard error of the mean.
TPM: Total particulate matter, GVP: Gas-vapor phase.
Relative cytotoxicity (%) ¼ (cytotoxicity of THS2.2 / 3R4F)  100.
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both tests under the three treatment conditions, TPM and GVP
derived from THS2.2 D2 and 3R4F induced concentration-
dependent increases in cytotoxicity and mutagenicity. In the
presence of S9, the mutagenic responses reproducibly surpassed
the GEF threshold for mutagenicity at or just above the cytotoxicity
limit of the assay, i.e. RTG 10%e20%. Increases in both large and
small colonies were observed for TPM and GVP derived from both
test articles. For THS2.2 D2, LOGELs for the TPM fraction were
markedly higher (on average 17-fold) than for 3R4F-derived TPM
(Fig. 4A and Table 13). A similar mutagenicity proﬁle was observed
for the GVP (Fig. 4B). In both treatment conditions (4 h and 24 h)
conducted in the absence of S9, mutagenicity which exceeded the
GEF threshold was also observed, however, this ﬁnding was not
always reproducible between the tests. When it was the case,
LOGELs for THS2.2 D2 -derived TPM were again markedly higher
(on average, at least 14-fold) than for 3R4F TPM (exemplar re-
sponses illustrated in Fig. 5A and Table 13). Moreover, in these
treatment conditions, the LOGELs for TPM always occurred at the
RTG 10%e20% cytotoxicity level. Similar mutagenicity proﬁles were
also observed for GVP under the same treatment conditions. Similar
results were obtained for the mentholated version of THS2.2
(exemplar responses illustrated in Figs. 5B and 6, and Table 13).
Mutagenicity data expressed on a per-mg TPM basis are presented
as part of the supplementary material (Supplementary Figures AeC
and Supplementary Table H).4. Discussion
The objective of this study was to assess the potential for
reduced exposure to HPHCs from THS2.2 compared with 3R4FTable 10
Cytotoxicity of TPM and GVP, expressed as 1/EC50 (ml/mg nicotine).
THS2.2 D2 3R4F analyzed during the THS2.2 D2 s
TPM GVP TPM GVP
Mean 17.34 28.40 208.55 289.06
SEM 0.52 1.20 6.92 22.38
N 3 3 3 3
Relative cytotoxicity (%) 8.3 9.8 100 100
SEM: Standard error of the mean.
TPM: Total particulate matter, GVP: Gas-vapor phase.
Relative cytotoxicity (%) ¼ (cytotoxicity of THS2.2/3R4F)  100.based on chemical analysis of HPHCs, in vitro genotoxicity, and
cytotoxicity assessments. To evaluate the robustness of the data for
the products under different conditions, HPHC yields were also
measured when using the product under simulated real-life
smoking conditions, additional tests were performed under
different climatic conditions and with different pufﬁng regimens.4.1. Aerosol physics and aerosol chemistry; comparison WITH the
3R4F reference cigarette
During this assessment of the THS2.2, following the feedback
from taste panels and to ensure sustainability of tobacco sources,
the blend FR1 was replaced by blend D2 for the regular product and
by blend D1 for the menthol product (Smith et al., 2016). Therefore,
it was considered important to present the chemical characteriza-
tion of all the four products (THS2.2 FR1, THS2.2 FR1 M, THS2.2 D2
and THS2.2 D1 M) in this publication. When comparing the four
products, it can be observed that they delivered HPHC yields that
were in the same range. The inﬂuence of the tobacco blend
composition on the HPHC yields is presented in the 3rd publication
of this issue (Schaller et al., 2016-b). When comparing menthol and
regular THS2.2 products, no substantial inﬂuence of menthol on the
HPHC yields was detected. Schmeltz and Schlotzhauer have re-
ported that menthol pyrolysis in a closed system produced benzo
[a]pyrene leading them to suggest that menthol pyrolysis could act
as a potential precursor to benzo[a]pyrene to the smoke of
mentholated cigarette products (Schmeltz and Schlotzhauer, 1968).
A signiﬁcant contribution of the menthol to the yield of benzo[a]
pyrene was not observed in the THS2.2. The FR1 Menthol product
deliverd a slightly higher yield of benzo[a]pyrene (1.29 ± 0.10 ng/
stick) than the FR1 Regular product (<1.00 ng/stick), but the yield of
menthol in the D1 Menthol product (1.08 ± 0.09 ng/stick) was on
the low side compared to the D2 Regular product (1.19 ± 0.08 ng/
stick). In addition, in the pyrolytic conditions used by Schmeltz and
Scholtzhauer, benzo[a]pyrene was detected only on pyrolysis of
menthol at 860 C, but not during pyrolysis at 600 C. Other studies
have reported that when isotopically labeled menthol was added to
tobacco of cigarettes, most of the menthol was transferred to the
smoke unchanged and the production of labeled benzo[a]pyrenetudy THS2.2 D1 M 3R4F analyzed during the THS2.2 D1 M study
TPM GVP TPM GVP
19.73 26.07 239.51 276.21
0.87 1.78 6.07 22.51
3 3 3 3
8.2 9.4 100 100
Fig. 4. The mutagenic responses induced by aerosol fractions derived from THS2.2 D2 and 3R4F in the 4 h þ S9 treatment condition in two independent tests expressed on a per-mg
nicotine basis. A. TPM. MFs for the DMSO-treated controls in tests #1 and #2 were 129.77 ± 22.57 and 78.73 ± 1.55 mutants/106 viable cells, respectively. THS2.2 D2 #1; THS2.2
D2 #2; 3R4F #1; 3R4F #2; GEF þ DMSO MF #1; GEF þ DMSO MF #2. B. GVP. MFs for the PBS-treated controls in tests #1 and #2 were 107.73 ± 10.40 and 69.44 ± 3.10
mutants/106 viable cells, respectively. THS2.2 D2 #1; THS2.2 D2 #2; 3R4F #1; 3R4F #2; GEF þ PBS MF #1; GEF þ PBS MF #2.
Table 12
Revertant colonies obtained following exposure to the TPM (1 mg per plate) from THS2.2 D2, THS2.2 D1 M, or 3R4F.
Salmonella typhimurium Strain THS2.2 D2 3R4Fa Solvent Control Positiveb Control THS2.2 D1 M 3R4Fa Solvent Control Positiveb Control
Meand SD Meand SD Meand SD Meand SD Meand SD Meand SD Meand SD Meand SD
þS9 TA98 22 4 658 89 21 1 109 7 21 2 636 24 25 2 97 17
TA100 94 21 428 25 87 2 481 22 93 12 440 20 90 6 471 67
TA102 358 12 409 15 272 22 1005 29 290 15 399 16 265 23 968 25
TA1535 9 3 17 6 6 1 70 8 15 6 15 6 10 3 113 11
TA1537 8 5 98 9 6 2 50 5 15 3 94 9 7 2 35 5
S9 TA98 16 4 17 5 23 6 81 6.2 22 3 10c 6 26 3 93 10
TA100 61 8 87 13 66 3 195 25 81 11 96 21 62 8 187 17
TA102 291 15 282 12 267 21 709 5 230 56 264 4 258 26 620 8
TA1535 12 3 7 3 6 2 37 8 9 4 16 6 12 2 51 6
TA1537 6 5 3 2 6 3 84 5 15 5 17 5 7 2 83 6
a These samples were generated and tested concurrently with the respective THS variant.
b Details of dose and substance are provided in the Ames methods section.
c Toxicity was detected at this dose.
d Each mean and SD value was derived from 3 plates and the values were rounded.
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Since (i) the heater blade temperature in the THS2.2 only reaches a
maximum temperature of 350 C, and (ii) available literature on
menthol pyrolysis to yield benzo[a]pyrene is limited, it was
concluded that menthol is unlikely to be a signiﬁcant source of
benzo[a]pyrene in the THS2.2 aerosol.
The mainstream aerosols produced by all the analyzed THS2.2
products were similar regarding analyte yields including HPHC
yields, but substantially different from the yields in mainstream
smoke of the 3R4F reference cigarette. To quantify the exposure
reduction, the yields of each HPHC for THS2.2 relative to those inTable 13
The LOGELs (expressed on a nicotine basis) achieved following treatment with TPM
(mg/ml) and GVP (mg nicotine equivalent/ml) derived from THS2.2 variants and 3R4F
values are shown when GEF threshold was exceeded.
4 h S9 4 h þS9 24 h S9
THS2.2 D2 TPM 18.66 34.48 41.80 17.31
GVP 71.90 83.17 249.87 300.99 43.14
3R4F TPM 1.31 2.47 1.91 1.14 1.05
GVP a 69.07 50.79 8.64 12.61
THS2.2 D1 M TPM 12.55 27.82 21.71 a
GVP 83.30 74.53 240.34 267.92 a
3R4F TPM 0.96 1.11 3.05 1.99 a
GVP 16.27 10.311 53.74 6.14
a Concentration-dependent increase inMF observed but below the GEF threshold.3R4F were calculated, and are presented on a per Tobacco Stick/
cigarette (Fig. 7). The graph presenting the results on a mg-nicotine
basis is included in the supplementary material (Figure D).
Fig. 7 presents a general view of the ratios between THS2.2 and
3R4F. The 100% line represents the yields of the 3R4F on a per-
cigarette basis. When considering the HPHC yields on a Tobacco
Stick/cigarette basis, it can be observed that acrylamide, ammonia,
butyraldehyde, butyraldehyde, acetamide, and mercury presented
ratios between 25 and 50%. Even if this denotes a substantial
reduction compared to 3R4F, it was not surprising to see ammonia,
acrylamide, acetamide and mercury at this level, since they could
be formed or could distill out of tobacco at relatively low temper-
atures (McDaniel et al., 2001; Stadler et al., 2002; Becalski et al.,
2003; Blank et al., 2005; Moldoveanu, 2010; Becalski et al., 2011).
The other analytes presented smaller ratios. Therefore, when
compared with 3R4F mainstream smoke, all HPHCs are consider-
ably reduced in the THS2.2 aerosol of the four products. This data
supports the hypothesis that the controlled heating of tobacco in
THS2.2 resulted in a signiﬁcant reduction in the pyrosynthesis of
HPHCs. When compared with 3R4F, the formation of polycyclic
aromatic hydrocarbons, aromatic amines, phenols, and aldehydes
was reduced by more than 75%, and for the majority of HPHCs, by
more than 90% under the HCI machine-smoking conditions. The
analyzed HPHCs covered a broad range of chemical compounds,
and several of these HPHCs have been described as markers for the
pyrolysis of tobacco (Moldoveanu, 2010). Since the reduction of
individual HPHCs was consistent across the different HPHC groups,
Fig. 5. The mutagenic responses induced by aerosol fractions derived from THS2.2 variants and 3R4F in the 4 hS9 treatment condition in two independent tests expressed on a
per-mg nicotine basis. A. TPM from THS2.2 D2 and 3R4F. MFs for the DMSO-treated controls in tests #1 and #2 were 99.52 ± 19.21 and 112.81 ± 23.41 mutants/106 viable cells,
respectively. THS2.2 D2 #1; THS2.2 D2 #2; 3R4F #1; 3R4F #2; GEF þ DMSO MF #1; GEF þ DMSO MF #2. B. GVP from THS2.2 D1 M and 3R4F. MFs for the PBS-treated
control(s) in tests #1 and #2 were 122.33 and 94.10 ± 26.37 mutants/106 viable cells, respectively. THS2.2 D1 M #1; THS2.2 D1 M #2; 3R4F #1; 3R4F #2; GEF þ PBS MF #1;
GEF þ PBS MF #2.
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similarly reduced. In addition, it can also be observed that some
HPHCs that could distill out of tobacco in 3R4F were also reduced in
the THS2.2 aerosol. The transfer of cadmium to the aerosols of the
four THS2.2 products could not be quantiﬁed (results below LOQ),
and the yield of TSNAs was minimal (Tables 5 and 6). Since the
nicotine yield was lower in the analyzed THS2.2 products than in
3R4F, the ratios calculated on a per-mg nicotine basis were some-
what higher. However, the trend remained the same, and the re-
ductions expressed on a per-mg nicotine basis were also substantial
(Figure D in the supplementary material).
The mainstream smoke of 3R4F and the THS2.2 aerosol gener-
ated under the HCI machine-smoking conditions were both shown
to be respirable aerosols (Table 9). The MMAD values were similar:
0.8 mm for 3R4F and 0.7 mm for THS2.2. The GSD was somewhat
higher for THS2.2 (Section 3.4). Therefore, THS2.2 presents respi-
rable properties that are similar to those of 3R4F, while reducing
substantially the levels of the measured HPHCs.
4.2. Chemical composition of the THS2.2 FR1 aerosol collected
under different climatic conditions and extreme PUFFING regimens
Since the THS2.2 may be used by consumers using pufﬁng
regimens under climatic conditions that deviate signiﬁcantly from
those considered in the HCI machine-smoking standard (55 ml puffFig. 6. The mutagenic responses induced by aerosol fractions derived from THS2.2 D1 M and
mg nicotine basis. A. TPM. MFs for the DMSO-treated controls in tests #1 and #2 were 89.
THS2.2 D1 M #2; 3R4F #1; 3R4F #2; GEF þ DMSO MF #1; GEF þ DMSO MF #2. B. GV
viable cells, respectively. THS2.2 D1 M #1; THS2.2 D1 M #2; 3R4F #1; 3R4F #2; Gevery 30 s, 22 C, 60% RH), the aerosol of the THS2.2 FR1 was
collected under different atmospheric and pufﬁng conditions
described in sections 2.5 and 2.6.
The climatic conditions may have a signiﬁcant impact on the
deliveries to the mainstream smoke of CC (Dymond and Hirji, 1972;
Boder and Senehi, 1984). In previous studies, the ﬁltration efﬁ-
ciency of the tobacco rod and of the ﬁlter and the puff count were
affected when CC were conditioned and smoked under different
climatic conditions. The effect could be observed on both gas phase
and particulate phase components. For instance, a temperature
increase of 10 C resulted in an increased delivery of nitric oxide by
18% for an American blend CC, while the phenol delivery decreased
correspondingly (Dymond and Hirji, 1972). It was anticipated that
the careful control of the heater blade temperature up to a
maximum of 350 C (Smith et al., 2016) and use of a low efﬁciency
ﬁlter would make THS2.2 less sensitive to variations in ambient
conditions and alterations in the yields of the different analytes.
The yield of water in the THS2.2 aerosol was considered the only
exception, because of the high humectant content of the tobacco
plug which contains glycerin in about 20% of the tobacco plug
weight. When the tobacco sticks were conditioned for at least 48 h
and used under “desert” conditions, the delivery of water was
considerably reduced when compared with the “tropical” condi-
tions (Table 7). The differences in the yield of water under both
“tropical” and “desert” conditions explained nearly all the3R4F in the 4 h þ S9 treatment condition in two independent tests expressed on a per-
01 ± 6.76 and 93.90 ± 13.64 mutants/106 viable cells, respectively. THS2.2 D1 M #1;
P. MFs for the PBS-treated control in tests #1 and #2 were 97.43 and 68.20 mutants/106
EF þ PBS MF #1; GEF þ PBS MF #2.
Fig. 7. Mainstream aerosol HPHCs from THS2.2 compared to the mainstream smoke HPHCs from the 3R4F reference cigarette (constituent levels set at 100%) on a per-unit basis
under the Health Canada Intense (HCI) machine-smoking regimen. When one value or more was below the LOQ, the results were not presented in the graphs (NAT: N-nitro-
soanatabine, NNK: 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone, NNN: N-nitrosonornicotine).
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the tobacco sticks in the three conditions (“Mediterranean”, “trop-
ical” and “desert”) were similar. The ranges for nicotine, formal-
dehyde, ethyl methyl ketone, acrylonitrile, 1,3-butadiene, benzene,
styrene, toluene, o-cresol, p-cresol, NNN, ammonia, and acetamide
were lower than the Intermediate Precision (IP) (International
Council for Harmonisation, 1996; Walﬁsh, 2006) of the respective
analytical methods, and the climatic conditions were considered
not to have a signiﬁcant impact on the yields of these HPHCs. The
ranges for other HPHCs were low, except for m-cresol, phenol, o-
toluidine, propylene oxide, and nitrobenzene, which had ranges in
excess of 35%. For o-toluidine, propylene oxide, and nitrobenzene,
the highest yield was obtained when conditioning and machine-
smoking the tobacco sticks at 22 C and 60% RH. Therefore, col-
lecting the aerosol under “tropical” or “desert” conditions did not
increase the yields of these HPHCs. The yield of m-cresol was
increased from 0.031 to 0.071 mg/stick under the “tropical” condi-
tion, while phenol was increased from 1.66 to 2.49 mg/stick under
the “desert” condition. However, the values remained low when
compared with the yields obtained from 3R4F: m-cresol (3.03 mg/
stick) and phenol (13.6 mg/stick) (Table 5). Therefore, the variation
of the climatic conditions had only a minor inﬂuence on the HPHC
yields.
The different machine-smoking pufﬁng regimens (Table 2) were
selected to cover the pufﬁng behavior reported for users of THS2.2
(Campelos et al., 2016). They induced signiﬁcant modiﬁcations of
the air ﬂow and of the quantity of air used to extract aerosol from
the tobacco plug in THS2.2. The minimum and maximum yields
obtained from the different machine-smoking regimens are pre-
sented in Table 8. In general, the yields of polar HPHCs (e.g. phenol
and cresol isomers) were more sensitive than apolar HPHCs to the
variation of the machine-smoking pufﬁng conditions (Table 8). For
each HPHC, the comparison between the maximum yield and the
yield obtained with the HCI smoking regimen should enable the
identiﬁcation of the HPHC for which the standard protocol may
underestimate the exposure when using more extreme pufﬁng
conditions. The ratios of maximum yield to HCI yield are presented
in Table 8. These ratios were less than 2 for 42 of 49 analyzed
compounds. Again, phenol and cresol isomers were the HPHCs
presenting the largest ratios. However, the HCI machine-smoking
protocol gave a relevant estimate of the exposure for the majority
of the tested HPHCs. Interestingly, the ratio obtained for nitrogen
oxides was only 1.1, and the ratio for COwas only 1.2. Since NOx and
CO can be considered potential markers of combustion (Norman
et al., 1983; Reed, 2002; Glarborg et al., 2003; Im et al., 2003;
Baker, 2006; Senneca et al., 2007; Cozzani et al., 2016), no evi-
dence of tobacco combustion was found even under extreme
machine-smoking pufﬁng conditions. Under extreme machine-
smoking pufﬁng conditions, the yields of all toxicologically rele-
vant compounds in the THS2.2 aerosol were lower than those ob-
tained when smoking the 3R4F reference cigarette under HCI
machine-smoking conditions (Table 5).
4.3. In vitro toxicology
The in vitro toxicology results reﬂect the chemistry data; THS2.2
aerosol fraction-induced effects are distinctly different in terms of
potency from those induced by counterpart fractions from 3R4F.
The THS2.2 aerosol demonstrates a substantial reduction in toxi-
cological activity compared with 3R4F smoke. In the NRU assay,
both the particulate phase and GVP in vitro cytotoxicity of THS2.2
Regular (FR1 and D2) and THS2.2 Menthol (FR1 and D1) were
reduced by 85%e95% compared with the 3R4F, independent of the
basis used to express the activity (per-mg TPM or per-mg nicotine)
(Table 10, Table 11 and Tables F and G of the supplementarymaterial).
The Ames assay did not reveal signiﬁcant mutagenicity of the
TPM fraction for either THS2.2 regular or THS2.2 menthol under the
conditions of this test. In contrast, the TPM fraction from 3R4F was
mutagenic in tester strains TA98, TA100, and TA1537 in the pres-
ence of the S9 metabolizing fraction from Aroclor-treated rat liver.
The MLA data show that both the TPM and GVP aerosol fractions
derived from THS2.2 D2 and THS2.2 D1 M were mutagenic in this
assay. However, the LOGELs demonstrate a lower in vitromutagenic
potency of the THS2.2 aerosol fractions compared with 3R4F. While
a conclusion underlying the mechanism(s) of this phenomenon
cannot be deﬁnitively made on the basis of these data, it is
reasonable to suggest that the overall reduction in the burden of
toxicants present in the THS2.2 aerosols may play a role in the
manifestation of reduced cytotoxic and mutagenic potency in vitro.
5. Conclusion
The low operating temperature of THS2.2 results in signiﬁcantly
lower concentrations of HPHCs in the mainstream aerosol
compared with the mainstream smoke of the 3R4F reference
cigarette when expressed on either a per-Tobacco Stick/cigarette or
a per-mg nicotine basis, while the MMAD of both aerosols remains
similar. The reductions in the concentrations of most HPHCs in the
THS2.2 aerosol were greater than 90% when compared with 3R4F,
and were not affected by machine-smoking of THS2.2 under
extreme climatic conditions. No evidence of tobacco combustion
was found when using the THS2.2 device with pufﬁng regimens
that were signiﬁcantly more intense than the HCI conditions. The
mutagenic and cytotoxic potencies of the mainstream aerosol
fractions from THS2.2, when evaluated by the Ames, mouse lym-
phoma, and NRU assays were reduced by at least 85%e95%
compared with the mainstream smoke aerosol of 3R4F.
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